SCHEMBL450856

SCHEMBL450856

CC(C(=O)O)C(CC(=O)O)C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.42
SLC22A6 Q4U2R8 1/20 0.39
SLC1A3 P43003 1/20 0.38
SLC1A2 P43004 1/20 0.38
SLC1A1 P43005 1/20 0.38
CYP1A2 P05177 1/20 0.37
CACNA2D1 P54289 2/20 0.37
CACNB3 P54284 1/20 0.37
CACNA1C Q13936 1/20 0.37
PGR P06401 1/20 0.37
ADRA1A P35348 1/20 0.37
HTR2B P41595 1/20 0.37
CACNA2D2 Q9NY47 1/20 0.37
TP53 P04637 1/20 0.36
FOLH1 Q04609 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphonic Acid SCHEMBL27829071 0.91 TDP1 (0.54) TDP1SMN1; SMN2SLC22A6SLC1A3SLC1A2
Phosphoric Acid SCHEMBL27904642 0.91 TDP1 (0.54) TDP1SMN1; SMN2SLC22A6SLC1A3SLC1A2
SCHEMBL27941678 0.85 TDP1 (0.59) TDP1SMN1; SMN2SLC22A6SLC1A3SLC1A2
SCHEMBL30768077 0.83 TDP1 (0.50) TDP1SMN1; SMN2SLC22A6CYP1A2CACNA2D1
SCHEMBL23060312 0.83 TDP1 (0.56) TDP1SMN1; SMN2SLC22A6SLC1A3SLC1A2
SCHEMBL259232 0.83 TDP1 (0.56) TDP1SMN1; SMN2SLC22A6SLC1A3SLC1A2
SCHEMBL28097728 0.83 TDP1 (0.56) TDP1SMN1; SMN2SLC22A6SLC1A3SLC1A2
SCHEMBL13352142 0.82 TDP1 (0.48) TDP1SLC1A3SLC1A2SLC1A1CYP1A2
SCHEMBL6631810 0.81 TDP1 (0.54) TDP1SMN1; SMN2SLC22A6SLC1A3SLC1A2
SCHEMBL5514949 0.81 TDP1 (0.68) TDP1SMN1; SMN2SLC22A6SLC1A3SLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 671 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12311321-B2 Anti-fouling and semi-permeable membrane AQUAPORIN A/S (DK) 2025-05-27 US claimed
CN-115461136-B Fouling resistant and semi-permeable membrane 水通道蛋白有限公司 2024-10-15 CN claimed
US-20230051090-A1 ABSORBENT UNDERGARMENT ESSITY HYGIENE AND HEALTH AKTIEBOLAG (SE) 2023-02-16 US claimed
EP-4107191-A1 A PLY FIBROUS PRODUCT Essity Hygiene and Health Aktiebolag (SE) 2022-12-28 EP claimed
EP-4103124-A1 ABSORBENT UNDERGARMENT Essity Hygiene and Health Aktiebolag (SE) 2022-12-21 EP claimed
CN-115461136-A Antifouling and semi-permeable membranes 水通道蛋白有限公司 2022-12-09 CN claimed
EP-4072713-A1 ANTI-FOULING AND SEMI-PERMEABLE MEMBRANE Aquaporin A/S (DK) 2022-10-19 EP claimed
CN-113529444-A White-bottom anti-staining soaping agent for nylon and preparation method thereof 广东传化富联精细化工有限公司 2021-10-22 CN claimed
WO-2021160627-A1 ABSORBENT UNDERGARMENT ESSITY HYGIENE AND HEALTH AKTIEBOLAG (SE) 2021-08-19 WO claimed
CN-103421518-B Crystal aligning agent and liquid crystal display device JSR CO., LTD. (JP) 2016-01-20 CN claimed
US-20100119835-A1 PHOTOCURABLE COMPOSITIONS FOR PREPARING ABS-LIKE ARTICLES HUNTSMAN INTERNATIONAL LLC (US) 2010-05-13 US claimed
EP-2118197-A1 PHOTOCURABLE COMPOSITIONS FOR PREPARING ABS-LIKE ARTICLES Huntsman Advanced Materials (Switzerland) GmbH (CH) 2009-11-18 EP claimed
WO-2008110512-A1 PHOTOCURABLE COMPOSITIONS FOR PREPARING ABS-LIKE ARTICLES HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) 2008-09-18 WO claimed
EP-1527078-A2 NOVEL PHOSPHONOCARBOXYLIC ACID ESTERS RHODIA CONSUMER SPECIALTIES LIMITED (GB) 2005-05-04 EP claimed
WO-2004002994-A2 NOVEL PHOSPHONOCARBOXYLIC ACID ESTERS RHODIA CONSUMER SPECIALITIES LIMITED (GB) 2004-01-08 WO claimed
US-6020520-A Process for the preparation of tetraalkyl 1,2,3,4-butanetetracarboxylates SOLUTIA INC. (US) 2000-02-01 US claimed
US-5460913-A Homogeneous dispersion of pigment in polymerizable monomer HODOGAYA CHEMICAL CO., LTD. (JP) 1995-10-24 US claimed
US-4196271-A 2-CYANOACRYLATE, POLYCARBOXYLIC ACID IMPACT STRENGTH IMPROVER TOAGOSEI CHEMICAL INDUSTRY CO., LTD. (JP) 1980-04-01 US claimed
US-3954858-A Novel sequestrant builders and method of making the same LEVER BROTHERS COMPANY (US) 1976-05-04 US claimed
JP-10140196-A None JP disclosed
US-20260055178-A1 ANTIBODY FORMULATIONS GENENTECH INC (US) 2026-02-26 US disclosed
US-20260049132-A1 ANTI-CONNEXIN ANTIBODY FORMULATIONS ALAMAB THERAPEUTICS INC (US) 2026-02-19 US disclosed
US-20250382370-A1 ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE GENENTECH, INC. (US) 2025-12-18 US disclosed
US-12492247-B2 Antibody formulations GENENTECH, INC. (US) 2025-12-09 US disclosed
US-12386265-B2 Pattern forming method and method for manufacturing electronic device FUJIFILM CORPORATION (JP) 2025-08-12 US disclosed
EP-4591881-A2 ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION F. Hoffmann-La Roche AG (CH) 2025-07-30 EP disclosed
EP-4331604-B9 ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION HOFFMANN LA ROCHE (CH) 2025-07-23 EP disclosed
US-12358981-B2 Anti-connexin antibody formulations ALAMAB THERAPEUTICS, INC. (US) 2025-07-15 US disclosed
WO-2025062847-A1 POROUS PARTICLE AND WATER-ABSORBING MATERIAL USING SAME 国立大学法人大阪大学 2025-03-27 WO disclosed
EP-4331604-B1 ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION HOFFMANN LA ROCHE (CH) 2025-03-05 EP disclosed
US-20250059397-A1 METHOD FOR PRODUCING WATER-BASED POLYESTER RESIN, AND WATER-BASED POLYESTER RESIN, AND METHOD FOR PRODUCING WATER-BASED COATING COMPOSITION, AND WATER-BASED COATING COMPOSITION GOO CHEMICAL CO., LTD. (JP) 2025-02-20 US disclosed
US-20250003077-A1 AQUEOUS SURFACE TREATMENT AGENT AND SURFACE-TREATED METAL NIPPON PAINT SURF CHEMICALS CO., LTD. (JP) 2025-01-02 US disclosed
CN-115461136-B Fouling resistant and semi-permeable membrane 水通道蛋白有限公司 2024-10-15 CN disclosed
US-12097996-B2 Container, method for manufacturing container, and chemical liquid storage body FUJIFILM CORPORATION (JP) 2024-09-24 US disclosed
US-20240295822-A1 PATTERN FORMING METHOD AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2024-09-05 US disclosed
US-12054548-B2 Anti-PD-L1 antibodies and use thereof ADAGENE, INC. (KY) 2024-08-06 US disclosed
WO-2024141537-A1 SULFONIUM SALT PHOTOINITIATORS AND METHODS OF LED CURING A COMPOSITION WITH SAID SULFONIUM SALT PHOTOINITIATORS ARKEMA FRANCE (FR) 2024-07-04 WO disclosed
WO-2024141543-A1 TRIARYLSULFONIUM BASED PHOTOINITIATORS FOR LED CURE OF CATIONIC, FREE RADICAL AND HYBRID CATIONIC/FREE RADICAL FORMULATIONS ARKEMA FRANCE (FR) 2024-07-04 WO disclosed
US-12013644-B2 Method for manufacturing electronic device FUJIFILM CORPORATION (JP) 2024-06-18 US disclosed
EP-4382633-A1 AQUEOUS SURFACE TREATMENT AGENT AND SURFACE-TREATED METAL Nippon Paint Surf Chemicals Co., Ltd. (JP) 2024-06-12 EP disclosed
WO-2024114644-A1 METHOD FOR PREPARING PHOTORESIST-GRAPHENE CONDUCTIVE COMPOSITE SYSTEM, CONDUCTIVE COMPOSITE SYSTEM OBTAINED THEREBY, AND USE THEREOF 北京师范大学 2024-06-06 WO disclosed
US-20240174799-A1 METHOD FOR PRODUCING WATER-BASED POLYESTER RESIN, WATER-BASED POLYESTER RESIN, AND WATER-BASED COATING COMPOSITION GOO CHEMICAL CO., LTD. (JP) 2024-05-30 US disclosed
EP-4370545-A1 STRUCTURES FOR REDUCING ANTIBODY-LIPASE BINDING Genentech, Inc. (US) 2024-05-22 EP disclosed
WO-2024068996-A1 ANTI-SARS-COV-2 ANTIBODIES AND USE THEREOF IN THE TREATMENT OF SARS-COV-2 INFECTION CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (C.H.U.V.) (CH) 2024-04-04 WO disclosed
US-11938189-B2 Compositions and methods for stabilizing protein-containing formulations GENENTECH, INC (US) 2024-03-26 US disclosed
US-20240085784-A1 ORGANIC EL DISPLAY DEVICE TOYO INK SC HOLDINGS CO., LTD. (JP) 2024-03-14 US disclosed
EP-4331604-A2 ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION F. Hoffmann-La Roche AG (CH) 2024-03-06 EP disclosed
CN-117642422-A Structure for reducing antibody-lipase binding 基因泰克公司 2024-03-01 CN disclosed
CN-114096602-B Composition and method for preparing sheets, films, fibers and shaped parts 洛桑联邦理工学院 (EPFL) 2024-02-13 CN disclosed
CN-117550943-A Based on CO 2 Method for participating in controllable synthesis of polycarboxylic acid compounds 四川大学 2024-02-13 CN disclosed
EP-4209510-B1 ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION HOFFMANN LA ROCHE (CH) 2024-01-31 EP disclosed
CN-117362436-A anti-PD-L1 antibodies and uses thereof 桂林三金药业股份有限公司 2024-01-09 CN disclosed
WO-2023248661-A1 PHOTOSENSITIVE COMPOSITION, HOLOGRAPHIC RECORDING MEDIUM, HOLOGRAPHIC OPTICAL ELEMENT, OPTICAL APPARATUS AND ELECTRONIC DEVICE ソニーグループ株式会社 2023-12-28 WO disclosed
CN-117120506-A Method for producing aqueous polyester resin, and aqueous coating composition 互应化学工业株式会社 2023-11-24 CN disclosed
US-20230364928-A1 INKJET INK, METHOD FOR MANUFACTURING PRINTED MATERIAL, AND PRINTED MATERIAL NATOCO CO., LTD. (JP) 2023-11-16 US disclosed
US-20230322998-A1 PHOTO-CURABLE RESIN COMPOSITION FOR USE IN STEREOLITHOGRAPHY BLUE CUBE IP LLC 2023-10-12 US disclosed
CN-116761909-A Aqueous surface treatment agent and surface-treated metal 日涂表面处理化工有限公司 2023-09-15 CN disclosed
US-20230287127-A1 ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE GENENTECH, INC. (US) 2023-09-14 US disclosed
CN-112424225-B anti-PD-L1 antibodies and uses thereof 桂林三金药业股份有限公司 2023-08-11 CN disclosed
EP-4218937-A2 ANTI-IL13 ANTIBODY FORMULATIONS F. Hoffmann-La Roche AG (CH) 2023-08-02 EP disclosed
WO-2023136092-A1 METHOD FOR PRODUCING AQUEOUS POLYESTER RESIN, AQUEOUS POLYESTER RESIN, METHOD FOR PRODUCING AQUEOUS COATING COMPOSITION, AND AQUEOUS COATING COMPOSITION 互応化学工業株式会社 2023-07-20 WO disclosed
EP-4209510-A1 ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION F. Hoffmann-La Roche AG (CH) 2023-07-12 EP disclosed
WO-2023126675-A1 HYBRID PHOTOCURABLE COMPOSITION ARKEMA FRANCE (FR) 2023-07-06 WO disclosed
EP-4206820-A1 HYBRID PHOTOCURABLE COMPOSITION ARKEMA FRANCE (FR) 2023-07-05 EP disclosed
EP-4179024-A1 A RADIATION CURABLE COMPOSITION COMPRISING A BIOBASED REACTIVE DILUENT Perstorp AB (SE) 2023-05-17 EP disclosed
CN-116077644-A Antibody formulations 弗·哈夫曼-拉罗切有限公司 2023-05-09 CN disclosed
EP-4169951-A1 ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION F. Hoffmann-La Roche AG (CH) 2023-04-26 EP disclosed
WO-2023037926-A1 AQUEOUS SURFACE TREATMENT AGENT AND SURFACE-TREATED METAL 日本ペイント・サーフケミカルズ株式会社 2023-03-16 WO disclosed
US-20230071802-A1 A PLY FIBROUS PRODUCT ESSITY HYGIENE AND HEALTH AKTIEBOLAG (SE) 2023-03-09 US disclosed
US-20230051090-A1 ABSORBENT UNDERGARMENT ESSITY HYGIENE AND HEALTH AKTIEBOLAG (SE) 2023-02-16 US disclosed
US-20230048743-A1 Structures for Reducing Antibody-Lipase Binding GENENTECH INC. (US) 2023-02-16 US disclosed
WO-2023288182-A1 STRUCTURES FOR REDUCING ANTIBODY-LIPASE BINDING GENENTECH, INC. (US) 2023-01-19 WO disclosed
EP-3702356-B1 EPOXY-OXETANE COMPOUND, METHOD FOR SYNTHESIZING SAME, AND USE OF SAID COMPOUND SHIKOKU CHEM (JP) 2023-01-11 EP disclosed
EP-4107191-A1 A PLY FIBROUS PRODUCT Essity Hygiene and Health Aktiebolag (SE) 2022-12-28 EP disclosed
EP-3091029-B1 ANTI-IL13 ANTIBODY FORMULATIONS HOFFMANN LA ROCHE (CH) 2022-12-28 EP disclosed
WO-2022263638-A1 ANTI-SARS-COV-2 ANTIBODIES AND USE THEREOF IN THE TREATMENT OF SARS-COV-2 INFECTION CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (C.H.U.V.) (CH) 2022-12-22 WO disclosed
EP-4103124-A1 ABSORBENT UNDERGARMENT Essity Hygiene and Health Aktiebolag (SE) 2022-12-21 EP disclosed
CN-115461136-A Antifouling and semi-permeable membranes 水通道蛋白有限公司 2022-12-09 CN disclosed
EP-4072713-A1 ANTI-FOULING AND SEMI-PERMEABLE MEMBRANE Aquaporin A/S (DK) 2022-10-19 EP disclosed
CN-109078182-B Antibody formulations 弗·哈夫曼-拉罗切有限公司 2022-08-12 CN disclosed
EP-4037703-A1 ANTO-CONNEXIN ANTIBODY FORMULATIONS Alamab Therapeutics, Inc. (US) 2022-08-10 EP disclosed
WO-2022162587-A1 ANTI-SARS-COV-2 ANTIBODIES AND USE THEREOF IN THE TREATMENT OF SARS-COV-2 INFECTION CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (C.H.U.V.) (CH) 2022-08-04 WO disclosed
CN-114835812-A anti-PD-L1 antibodies and their use for enhancing T cell function 霍夫曼-拉罗奇有限公司 2022-08-02 CN disclosed
CN-114786719-A Anti-connexin antibody formulations 阿拉玛布治疗学股份有限公司 2022-07-22 CN disclosed
EP-4008313-A1 COMPOSITIONS AND METHODS FOR STABLIZING PROTEIN-CONTAINING FORMULATIONS F. Hoffmann-La Roche AG (CH) 2022-06-08 EP disclosed
US-20220125928-A1 COMPOSITIONS AND METHODS FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS GENENTECH, INC. (US) 2022-04-28 US disclosed
US-20220121123-A1 METHOD FOR MANUFACTURING ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2022-04-21 US disclosed
US-11256173-B2 Treatment liquid for manufacturing semiconductor and pattern forming method FUJIFILM CORPORATION (JP) 2022-02-22 US disclosed
EP-3946457-A1 COMPOSITIONS AND METHODS FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS Genentech, Inc. (US) 2022-02-09 EP disclosed
WO-2022010403-A1 A RADIATION CURABLE COMPOSITION COMPRISING A BIOBASED REACTIVE DILUENT PERSTORP AB (SE) 2022-01-13 WO disclosed
EP-3929216-A1 ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION F. Hoffmann-La Roche AG (CH) 2021-12-29 EP disclosed
US-20210353756-A1 COMPOSITIONS AND METHODS FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS GENENTECH, INC. (US) 2021-11-18 US disclosed
CN-113660953-A Compositions and methods for stabilizing protein-containing formulations 豪夫迈·罗氏有限公司 2021-11-16 CN disclosed
CN-113529444-A White-bottom anti-staining soaping agent for nylon and preparation method thereof 广东传化富联精细化工有限公司 2021-10-22 CN disclosed
WO-2021160627-A1 ABSORBENT UNDERGARMENT ESSITY HYGIENE AND HEALTH AKTIEBOLAG (SE) 2021-08-19 WO disclosed
US-20210237484-A1 METHOD FOR PRODUCING INKJET PRINTED MATERIAL AND INKJET PRINTED MATERIAL NATOCO CO., LTD. (JP) 2021-08-05 US disclosed
US-11066509-B2 Conductive paste composition, device comprising electrode formed from same, and method for producing conductive paste composition KANEKA CORPORATION (JP) 2021-07-20 US disclosed
US-20210155684-A1 Antibody Formulations GENENTECH, INC. 2021-05-27 US disclosed
EP-3586826-B1 COMPOSITIONS AND METHODS FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS HOFFMANN LA ROCHE (CH) 2021-05-12 EP disclosed
US-20210122824-A1 ANTI-PD-L1 ANTIBODIES AND USE THEREOF ADAGENE, INC. (KY) 2021-04-29 US disclosed
WO-2021067775-A1 ANTO-CONNEXIN ANTIBODY FORMULATIONS ALAMAB THERAPEUTICS, INC. (US) 2021-04-08 WO disclosed
US-20210101974-A1 ANTI-CONNEXIN ANTIBODY FORMULATIONS ALAMAB THERAPEUTICS, INC. 2021-04-08 US disclosed
US-10947307-B2 Antibody formulations GENENTECH, INC (US) 2021-03-16 US disclosed
CN-112424225-A anti-PD-L1 antibodies and uses thereof 桂林三金药业股份有限公司 2021-02-26 CN disclosed
US-10913731-B2 Epoxy-oxetane compound, method for synthesizing same, and use of said compound SHIKOKU CHEMICALS CORPORATION (JP) 2021-02-09 US disclosed
US-20210032345-A1 ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE GENENTECH, INC. (US) 2021-02-04 US disclosed
WO-2020205716-A1 COMPOSITIONS AND METHODS FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS GENENTECH, INC. (US) 2020-10-08 WO disclosed
EP-3702356-A1 EPOXY-OXETANE COMPOUND, METHOD FOR SYNTHESIZING SAME, AND USE OF SAID COMPOUND Shikoku Chemicals Corporation (JP) 2020-09-02 EP disclosed
US-20200270236-A1 EPOXY-OXETANE COMPOUND, METHOD FOR SYNTHESIZING SAME, AND USE OF SAID COMPOUND SHIKOKU CHEMICALS CORPORATION (JP) 2020-08-27 US disclosed
US-20200115105-A1 CONTAINER, METHOD FOR MANUFACTURING CONTAINER, AND CHEMICAL LIQUID STORAGE BODY FUJIFILM CORPORATION (JP) 2020-04-16 US disclosed
US-20200095370-A1 CONDUCTIVE PASTE COMPOSITION, DEVICE COMPRISING ELECTRODE FORMED FROM SAME, AND METHOD FOR PRODUCING CONDUCTIVE PASTE COMPOSITION KANEKA CORPORATION (JP) 2020-03-26 US disclosed
US-10478473-B2 Compositions and methods of using anti-mullerian hormone for treatment of infertility THE CENTER FOR HUMAN REPRODUCTION (CHR) (US) 2019-11-19 US disclosed
US-10463581-B2 Sealer composition for root canal filling SHOFU INC. (JP) 2019-11-05 US disclosed
CN-110201550-A A kind of corrosion inhibiting and descaling agent for reverse osmosis membrane 营口科林膜技术工程服务有限公司 2019-09-06 CN disclosed
EP-2585045-B1 COMPOSITIONS AND METHODS CONTAINING ALKYLGYCOSIDES FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS HOFFMANN LA ROCHE (CH) 2019-08-21 EP disclosed
EP-3513810-A1 COMPOSITIONS AND METHODS USEFUL FOR STABILIZING PROTEIN- CONTAINING FORMULATIONS F. Hoffmann-La Roche AG (CH) 2019-07-24 EP disclosed
US-20190216929-A1 COMPOSITIONS AND METHODS FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS GENENTECH, INC. (US) 2019-07-18 US disclosed
EP-2524914-B1 SULFONIC ACID DERIVATIVE COMPOUND AND NAPHTHALIC ACID DERIVATIVE COMPOUND ADEKA CORP (JP) 2019-07-03 EP disclosed
CN-109574118-A A kind of sewage treatment composite drug and preparation method thereof 嘉兴沃特泰科环保科技有限公司 2019-04-05 CN disclosed
US-10208183-B2 Curable composition, film, and method of producing film CANON KABUSHIKI KAISHA (JP) 2019-02-19 US disclosed
US-10188735-B2 Compositions and methods for stabilizing protein-containing formulations GENENTECH, INC. (US) 2019-01-29 US disclosed
US-20190025702-A1 TREATMENT LIQUID FOR MANUFACTURING SEMICONDUCTOR AND PATTERN FORMING METHOD FUJIFILM CORPORATION (JP) 2019-01-24 US disclosed
US-20190016807-A1 ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE GENENTECH, INC. (US) 2019-01-17 US disclosed
US-20190002552-A1 ANTIBODY FORMULATIONS DERMIRA, INC. 2019-01-03 US disclosed
CN-109078182-A Antibody preparation 弗·哈夫曼-拉罗切有限公司 2018-12-25 CN disclosed
CN-108997498-A Anti- PD-L1 antibody and they be used to enhance the purposes of T cell function 霍夫曼-拉罗奇有限公司 2018-12-14 CN disclosed
CN-108885412-A Processing liquid for semiconductor manufacturing and pattern forming method 富士胶片株式会社 2018-11-23 CN disclosed
CN-108704132-A Antibody preparation 弗·哈夫曼-拉罗切有限公司 2018-10-26 CN disclosed
CN-104479018-B Anti- PD-L1 antibody and they be used to enhance the purposes of T cell function 霍夫曼-拉罗奇有限公司 2018-09-21 CN disclosed
EP-2137576-B1 DUAL PHOTOINITIATOR, PHOTOCURABLE COMPOSITION, USE THEREOF AND PROCESS FOR PRODUCING A THREE DIMENSIONAL ARTICLE 3D SYSTEMS INCORPORATED (US) 2018-08-29 EP disclosed
US-20180236034-A1 Compositions and Methods of Using Anti-Mullerian Hormone for Treatment of Infertility UNIVERSITY OF ROCHESTER 2018-08-23 US disclosed
US-10034940-B2 High concentration antibody and protein formulations GENENTECH, INC. (US) 2018-07-31 US disclosed
CN-105829097-B Article with metal oxide film 福吉米株式会社 2018-06-26 CN disclosed
US-10000562-B2 Antibody formulations GENENTECH, INC. (US) 2018-06-19 US disclosed
EP-1941322-B1 ANTIMONY-FREE PHOTOCURABLE RESIN COMPOSITION AND THREE DIMENSIONAL ARTICLE 3D SYSTEMS INC (US) 2018-05-30 EP disclosed
US-9982102-B2 Photocurable composition and method of manufacturing film using the composition CANON KABUSHIKI KAISHA (JP) 2018-05-29 US disclosed
US-9976100-B2 Lubricant composition FUJIFILM CORPORATION (JP) 2018-05-22 US disclosed
EP-2726509-B1 USE OF ANTI-CD83 AGONIST ANTIBODIES FOR TREATING AUTOIMMUNE DISEASES HOFFMANN LA ROCHE (CH) 2018-05-02 EP disclosed
US-9961776-B2 Method of producing cured product and method of forming pattern CANON KABUSHIKI KAISHA (JP) 2018-05-01 US disclosed
US-9920123-B2 Anti-PD-L1 antibodies, compositions and articles of manufacture GENENTECH, INC. (US) 2018-03-20 US disclosed
EP-3265111-A2 COMPOSITIONS AND METHODS OF USING ANTI-MULLERIAN HORMONE FOR TREATMENT OF INFERTILITY The University of Rochester (US) 2018-01-10 EP disclosed
US-9834736-B2 Lubricating oil composition for internal combustion engines of passenger and commercial four-wheeled vehicles FUJIFILM CORPORATION (JP) 2017-12-05 US disclosed
EP-3053974-B1 PIGMENT DISPERSION COMPOSITION, INKJET RECORDING METHOD, AND METHOD FOR PRODUCING COMPOUND FUJIFILM CORP (JP) 2017-10-25 EP disclosed
US-9790386-B2 Ink composition, two-pack curing ink composition set, and recording method and recorded matter using these SEIKO EPSON CORPORATION (JP) 2017-10-17 US disclosed
EP-2376535-B9 ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION HOFFMANN LA ROCHE (CH) 2017-09-13 EP disclosed
US-20170231874-A1 SEALER COMPOSITION FOR ROOT CANAL FILLING SHOFU INC. (JP) 2017-08-17 US disclosed
US-20170224820-A1 COMPOSITIONS AND METHODS USEFUL FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS GENENTECH INC (US) 2017-08-10 US disclosed
US-9716024-B2 Temporary bonding laminates for used in manufacture of semiconductor devices FUJIFILM CORPORATION (JP) 2017-07-25 US disclosed
EP-3178492-A1 HIGH CONCENTRATION ANTIBODY AND PROTEIN FORMULATIONS Genentech, Inc. (US) 2017-06-14 EP disclosed
US-9676899-B2 Radiation curable resin composition and rapid three dimensional imaging process using the same DSM IP ASSETS B.V. (NL) 2017-06-13 US disclosed
US-9662395-B2 Compositions and methods useful for stabilizing protein-containing formulations GENENTECH, INC. (US) 2017-05-30 US disclosed
US-9643404-B2 Pigment dispersion composition, inkjet recording method, and method for producing compound FUJIFILM CORPORATION (JP) 2017-05-09 US disclosed
US-20170107287-A1 METHODS OF USING ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION TO TREAT TUMOR IMMUNITY GENENTECH, INC. (US) 2017-04-20 US disclosed
EP-2376535-B1 ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION HOFFMANN LA ROCHE (CH) 2017-04-12 EP disclosed
CN-103906766-B Anti- CD83 agonist antibody is used for treating the purposes of autoimmune disease 弗·哈夫曼-拉罗切有限公司 2017-03-08 CN disclosed
US-20170049888-A1 HIGH CONCENTRATION ANTIBODY AND PROTEIN FORMULATIONS GENENTECH INC (US) 2017-02-23 US disclosed
US-9562097-B2 Use of anti-CD83 agonist antibodies for treating autoimmune diseases GENENTECH, INC. (US) 2017-02-07 US disclosed
US-9564638-B2 Battery electrode or separator surface protective agent composition, battery electrode or separator protected by the composition, and battery having the battery electrode or separator KYORITSU CHEMICAL & CO., LTD. (JP) 2017-02-07 US disclosed
US-20170012022-A1 PHOTOSENSITIVE RESIN COMPOSITION, LAMINATE, METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE FUJIFILM CORPORATION (JP) 2017-01-12 US disclosed
US-9526804-B2 Injectable biodegradable particles BOSTON SCIENTIFIC SCIMED, INC. (US) 2016-12-27 US disclosed
US-20160362624-A1 LUBRICANT COMPOSITION FUJIFILM CORPORATION (JP) 2016-12-15 US disclosed
EP-3091029-A1 ANTI-IL13 ANTIBODY FORMULATIONS F. Hoffmann-La Roche AG (CH) 2016-11-09 EP disclosed
EP-2335725-B1 High concentration antibody and protein formulations GENENTECH INC (US) 2016-10-12 EP disclosed
US-9463623-B2 Liquid ejection head and image forming apparatus incorporating same RICOH COMPANY, LTD. (JP) 2016-10-11 US disclosed
US-20160289591-A1 LUBRICATING OIL COMPOSITION FOR INTERNAL COMBUSTION ENGINES OF PASSENGER AND COMMERCIAL FOUR-WHEELED VEHICLES FUJIFILM CORPORATION (JP) 2016-10-06 US disclosed
CN-103554263-B Apoptotic anti-IgE antibodies in conjunction with the IgE that film combines 健泰科生物技术公司 2016-09-28 CN disclosed
CN-103068367-B Compositions and methods comprising alkylglycosides for stabilizing protein-containing formulations 弗·哈夫曼-拉罗切有限公司 2016-09-07 CN disclosed
EP-2551123-B1 Printing method, printed material and molded article SEIKO EPSON CORP (JP) 2016-08-17 EP disclosed
EP-3053974-A1 PIGMENT DISPERSION COMPOSITION, INKJET RECORDING METHOD, AND METHOD FOR PRODUCING COMPOUND FUJIFILM Corporation (JP) 2016-08-10 EP disclosed
US-20160222117-A1 NUCLEIC ACID ENCODING ANTI-PD-L1 ANTIBODIES GENENTECH, INC. (US) 2016-08-04 US disclosed
US-20160200926-A1 PIGMENT DISPERSION COMPOSITION, INKJET RECORDING METHOD, AND METHOD FOR PRODUCING COMPOUND FUJIFILM CORPORATION (JP) 2016-07-14 US disclosed
US-20160199494-A1 COMPOSITIONS AND METHODS FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS GENENTECH, INC. (US) 2016-07-14 US disclosed
US-20160178816-A1 NEAR-INFRARED-ABSORBING COMPOSITION, NEAR-INFRARED CUT FILTER OBTAINED USING SAME, PROCESS FOR PRODUCING SAID CUT FILTER, CAMERA MODULE AND PROCESS FOR PRODUCING SAME, AND SOLID PHOTOGRAPHING ELEMENT FUJIFILM CORPORATION (JP) 2016-06-23 US disclosed
US-20160160003-A1 CURABLE COMPOSITION, FILM, AND METHOD OF PRODUCING FILM CANON KABUSHIKI KAISHA (JP) 2016-06-09 US disclosed
EP-3010943-A1 CURABLE COMPOSITION, FILM, AND METHOD OF PRODUCING FILM Canon Kabushiki Kaisha (JP) 2016-04-27 EP disclosed
US-20160104635-A1 TEMPORARY BONDING LAMINATES FOR USED IN MANUFACTURE OF SEMICONDUCTOR DEVICES AND METHODS FOR MANUFACTURING SEMICONDUCTOR DEVICES FUJIFILM CORPORATION (JP) 2016-04-14 US disclosed
US-9308552-B2 Curable composition and method of forming pattern CANON KABUSHIKI KAISHA (JP) 2016-04-12 US disclosed
US-20160075922-A1 TEMPORARY ADHESIVE FOR PRODUCTION OF SEMICONDUCTOR DEVICE, AND ADHESIVE SUPPORT AND PRODUCTION METHOD OF SEMICONDUCTOR DEVICE USING THE SAME FUJIFILM CORPORATION (JP) 2016-03-17 US disclosed
EP-2991483-A2 HIGH OSMOLARITY ANTIMICROBIAL COMPOSITION CONTAINING ONE OR MORE ORGANIC SOLVENTS Next Science, LLC (US) 2016-03-09 EP disclosed
US-9254321-B2 Compositions and methods for stabilizing protein-containing formulations GENENTECH, INC. (US) 2016-02-09 US disclosed
US-9242498-B2 Printing method, printing device, printed material and molded article SEIKO EPSON CORPORATION (JP) 2016-01-26 US disclosed
US-20150368490-A1 Ink Composition, Two-Pack Curing Ink Composition Set, And Recording Method And Recorded Matter Using These SEIKO EPSON CORP (JP) 2015-12-24 US disclosed
US-20150322153-A1 ANTI-PD-L1 ANTIBODIES AND ARTICLES OF MANUFACTURE GENENTECH, INC. (US) 2015-11-12 US disclosed
US-9169410-B2 Ink composition, two-pack curing ink composition set, and recording method and recorded matter using these SEIKO EPSON CORPORATION (JP) 2015-10-27 US disclosed
US-20150284603-A1 TEMPORARY ADHESIVE FOR PRODUCTION OF SEMICONDUCTOR DEVICE, AND ADHESIVE SUPPORT AND PRODUCTION METHOD OF SEMICONDUCTOR DEVICE USING THE SAME FUJIFILM CORPORATION (JP) 2015-10-08 US disclosed
US-20150225485-A1 HIGH CONCENTRATION ANTIBODY AND PROTEIN FORMULATIONS NOVARTIS PHARMACEUTICALS CORPORATION 2015-08-13 US disclosed
US-9090020-B2 Photo-curable resin composition DSM IP ASSETS B.V. (NL) 2015-07-28 US disclosed
EP-2186799-B1 AROMATIC SULFONIUM SALT COMPOUND ADEKA CORP (JP) 2015-07-08 EP disclosed
US-9073854-B2 Aromatic sulfonium salt compound ADEKA CORPORATION (JP) 2015-07-07 US disclosed
US-9076999-B2 Laminating water-based surface treatment agent, surface treatment method and surface treated material SHOWA DENKO PACKAGING CO., LTD. (JP) 2015-07-07 US disclosed
US-20150183942-A1 PHOTOCURABLE COMPOSITION AND METHOD OF MANUFACTURING FILM USING THE COMPOSITION CANON KABUSHIKI KAISHA (JP) 2015-07-02 US disclosed
US-9065138-B2 Water soluble binder composition, method of producing the same and electrode for rechargeable battery employing the same SAMSUNG SDI CO., LTD. (KR) 2015-06-23 US disclosed
CN-104662713-A Negative electrode for secondary batteries, and secondary battery SHOWA DENKO KK 2015-05-27 CN disclosed
US-9034939-B2 Primer for ink-jet recording HITACHI MAXELL, LTD. (JP) 2015-05-19 US disclosed
US-20150093879-A1 TEMPORARY ADHESIVE FOR PRODUCTION OF SEMICONDUCTOR DEVICE, AND ADHESIVE SUPPORT AND PRODUCTION METHOD OF SEMICONDUCTOR DEVICE USING THE SAME FUJIFILM CORPORATION (JP) 2015-04-02 US disclosed
CN-104479018-A Anti-pd-l1 antibodies and their use to enhance t-cell function HOFFMANN LA ROCHE 2015-04-01 CN disclosed
EP-2847234-A1 PHOTOCURABLE COMPOSITION AND METHOD OF MANUFACTURING FILM USING THE COMPOSITION Canon Kabushiki Kaisha (JP) 2015-03-18 EP disclosed
EP-2847235-A1 PHOTOCURABLE COMPOSITION AND METHOD OF MANUFACTURING FILM USING THE COMPOSITION Canon Kabushiki Kaisha (JP) 2015-03-18 EP disclosed
WO-2015030258-A1 CURABLE COMPOSITION, FILM, AND METHOD OF PRODUCING FILM CANON KABUSHIKI KAISHA (JP) 2015-03-05 WO disclosed
EP-2841255-A1 RESIN PRODUCTION METHOD AND RESIN PRODUCTION APPARATUS Canon Kabushiki Kaisha (JP) 2015-03-04 EP disclosed
US-8961964-B2 High concentration antibody and protein formulations GENENTECH, INC. (US) 2015-02-24 US disclosed
US-8956716-B2 Printed material and method for manufacturing printed metal SEIKO EPSON CORPORATION (JP) 2015-02-17 US disclosed
US-8945439-B2 Method for manufacturing lens, apparatus for manufacturing lens, and method for manufacturing optical apparatus CANON KABUSHIKI KAISHA (JP) 2015-02-03 US disclosed
US-20150004790-A1 PHOTOCURED PRODUCT AND METHOD FOR PRODUCING THE SAME CANON KABUSHIKI KAISHA (JP) 2015-01-01 US disclosed
CN-102245640-B Anti-PD-L1 antibodies and their use for enhancing T cell function HOFFMANN LA ROCHE 2014-12-31 CN disclosed
US-20140363584-A1 METHOD OF PRODUCING CURED PRODUCT AND METHOD OF FORMING PATTERN CANON KABUSHIKI KAISHA (JP) 2014-12-11 US disclosed
EP-2809684-A1 ANTI-IG-E M1' ANTIBODIES AND METHODS USING SAME Genentech, Inc. (US) 2014-12-10 EP disclosed
US-20140348855-A1 ANTIBODY FORMULATIONS GENENTECH, INC. (US) 2014-11-27 US disclosed
WO-2014179754-A2 HIGH OSMOLARITY ANTIMICROBIAL COMPOSITION CONTAINING ONE OR MORE ORGANIC SOLVENTS NEXT SCIENCE, LLC (US) 2014-11-06 WO disclosed
US-8871133-B2 Method and composition for reducing waste in photo-imaging applications DSM IP ASSETS B.V. (NL) 2014-10-28 US disclosed
EP-2791965-A1 PHOTOCURED PRODUCT AND METHOD FOR PRODUCING THE SAME Canon Kabushiki Kaisha (JP) 2014-10-22 EP disclosed
CN-103119122-B Manufacturing method of polishing liquid composition KAO CORP. (JP) 2014-10-08 CN disclosed
US-8853290-B2 Photosensitive composition SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2014-10-07 US disclosed
US-20140286950-A1 USE OF ANTI-CD83 AGONIST ANTIBODIES FOR TREATING AUTOIMMUNE DISEASES GENENTECH, INC. (US) 2014-09-25 US disclosed
US-20140267497-A1 LIQUID EJECTION HEAD AND IMAGE FORMING APPARATUS INCORPORATING SAME RICOH COMPANY, LTD. (JP) 2014-09-18 US disclosed
EP-2773662-A1 ANTIBODY FORMULATIONS F.HOFFMANN-LA ROCHE AG (CH) 2014-09-10 EP disclosed
CN-104039826-A Antibody formulations HOFFMANN LA ROCHE 2014-09-10 CN disclosed
US-8808974-B2 Method for forming pattern JSR CORPORATION (JP) 2014-08-19 US disclosed
US-8802570-B2 Pattern forming method CANON KABUSHIKI KAISHA (JP) 2014-08-12 US disclosed
WO-2014116749-A1 ANTI-HCV ANTIBODIES AND METHODS OF USING THEREOF GENENTECH, INC. (US) 2014-07-31 WO disclosed
EP-2758987-A1 METHOD OF FORMING FILM Canon Kabushiki Kaisha (JP) 2014-07-30 EP disclosed
CN-103906766-A Use of anti-cd83 agonist antibodies for treating autoimmune diseases HOFFMANN LA ROCHE 2014-07-02 CN disclosed
EP-2059565-B1 MODIFIED COLORANTS WITH ALIPHATIC POLY-ACID GROUPS CABOT CORP (US) 2014-06-11 EP disclosed
EP-2726509-A1 USE OF ANTI-CD83 AGONIST ANTIBODIES FOR TREATING AUTOIMMUNE DISEASES Genentech, Inc. (US) 2014-05-07 EP disclosed
US-8715901-B2 Resin composition for forming fine pattern and method for forming fine pattern JSR CORPORATION (JP) 2014-05-06 US disclosed
US-20140115729-A1 APOPTOTIC ANTI-IGE ANTIBODIES GENENTECH, INC. (US) 2014-04-24 US disclosed
EP-2132230-B1 APOPTOTIC ANTI-IGE ANTIBODIES BINDING THE MEMBRANE-BOUND IGE GENENTECH INC (US) 2014-04-16 EP disclosed
WO-2014046304-A1 PHOTOCURABLE COMPOSITION AND METHOD OF MANUFACTURING FILM USING THE COMPOSITION CANON KABUSHIKI KAISHA (JP) 2014-03-27 WO disclosed
WO-2014046150-A1 PHOTOCURABLE COMPOSITION AND METHOD OF MANUFACTURING FILM USING THE COMPOSITION CANON KABUSHIKI KAISHA (JP) 2014-03-27 WO disclosed
EP-2511101-B1 Printed material and method for manufacturing printed material SEIKO EPSON CORP (JP) 2014-03-26 EP disclosed
US-8680268-B2 Sulfonic acid derivative compound and novel naphthalic acid derivative compound ADEKA CORPORATION (JP) 2014-03-25 US disclosed
US-8673994-B2 Ink composition, two-pack curing ink composition set, and recording method and recorded matter using these SEIKO EPSON CORPORATION (JP) 2014-03-18 US disclosed
US-20140065135-A1 METHODS OF USING ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION TO TREAT TUMOR IMMUNITY GENENTECH, INC. (US) 2014-03-06 US disclosed
CN-203440569-U Textile product NISSHINBO TEXTILE INC 2014-02-19 CN disclosed
US-20140045966-A1 PHOTOSENSITIVE COMPOSITION. CURED ARTICLE, AND METHOD FOR PRODUCING ACTINICALLY CURED ARTICLE SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2014-02-13 US disclosed
US-20140035202-A1 RADIATION CURABLE RESIN COMPOSITION AND RAPID THREE-DIMENSIONAL IMAGING PROCESS USING THE SAME DSM IP ASSETS B.V. (NL) 2014-02-06 US disclosed
CN-103554263-A Apoptotic anti- IgE antibodies binding the membrane-bound IgE GENENTECH INC 2014-02-05 CN disclosed
WO-2014017505-A1 RESIN PRODUCTION METHOD AND RESIN PRODUCTION APPARATUS CANON KABUSHIKI KAISHA (JP) 2014-01-30 WO disclosed
US-8632775-B2 Apoptotic anti-IgE antibodies GENENTECH, INC. (US) 2014-01-21 US disclosed
US-8618274-B2 Nucleic acid encoding apoptotic anti-IgE antibodies GENENTECH, INC. (US) 2013-12-31 US disclosed
US-8592550-B2 Process for the preparation of polycarbonates STICHTING DUTCH POLYMER INSTITUTE (NL) 2013-11-26 US disclosed
US-8586040-B2 Methods of using apoptotic anti-IGE antibodies GENENTECH, INC. (US) 2013-11-19 US disclosed
US-8580384-B2 Dielectric materials and methods of preparation and use thereof POLYERA CORPORATION (US) 2013-11-12 US disclosed
US-8580384-B2 Dielectric materials and methods of preparation and use thereof POLYERA CORPORATION (US) 2013-11-12 US disclosed
CN-101679528-B Apoptotic anti-IgE antibodies that bind membrane-bound IgE GENENTECH INC 2013-11-06 CN disclosed
US-20130280593-A1 LAMINATING WATER-BASED SURFACE TREATMENT AGENT, SURFACE TREATMENT METHOD AND SURFACE TREATED MATERIAL SHOWA DENKO K.K. (JP) 2013-10-24 US disclosed
US-20130273423-A1 WATER SOLUBLE BINDER COMPOSITION, METHOD OF PRODUCING THE SAME AND ELECTRODE FOR RECHARGEABLE BATTERY EMPLOYING THE SAME SAMSUNG SDI CO., LTD. (KR) 2013-10-17 US disclosed
US-20130267627-A1 PRIMER FOR INK-JET RECORDING HITACHI MAXELL, LTD. (JP) 2013-10-10 US disclosed
US-20130260207-A1 BATTERY ELECTRODE OR SEPARATOR SURFACE PROTECTIVE AGENT COMPOSITION, BATTERY ELECTRODE OR SEPARATOR PROTECTED BY THE COMPOSITION, AND BATTERY HAVING THE BATTERY ELECTRODE OR SEPARATOR KYORITSU CHEMICAL & CO., LTD. (JP) 2013-10-03 US disclosed
EP-2644621-A1 Apoptotic anti-IgE antibodies Genentech, Inc. (US) 2013-10-02 EP disclosed
US-20130243750-A1 ANTI-IGE ANTIBODIES AND METHODS USING SAME GENENTECH, INC. (US) 2013-09-19 US disclosed
WO-2013129705-A1 MANUFACTURING METHOD OF SEMICONDUCTOR DEVICE FUJIFILM CORPORATION (JP) 2013-09-06 WO disclosed
US-20130224213-A1 Compositions and Methods for Stabilizing Protein-Containing Formulations GENETECH, INC. (US) 2013-08-29 US disclosed
EP-1610820-B2 HIGH CONCENTRATION ANTIBODY AND PROTEIN FORMULATIONS GENENTECH INC (US) 2013-08-21 EP disclosed
WO-2013118791-A1 PHOTOCURED PRODUCT AND METHOD FOR PRODUCING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-08-15 WO disclosed
US-20130203882-A1 Curable Composition HUNTSMAN INTERNATIONAL LLC (US) 2013-08-08 US disclosed
WO-2013116287-A1 ANTI-IG-E M1' ANTIBODIES AND METHODS USING SAME GENENTECH, INC. (US) 2013-08-08 WO disclosed
US-8501033-B2 Radiation curable resin composition and rapid three-dimensional imaging process using the same DSM IP ASSETS B.V. (NL) 2013-08-06 US disclosed
US-8492505-B2 Branched biodegradable polymers, a macromonomer, processes for the preparation of same, and their use UNIVERSITY OF TWENTE (NL) 2013-07-23 US disclosed
US-8492505-B2 Branched biodegradable polymers, a macromonomer, processes for the preparation of same, and their use UNIVERSITY OF TWENTE (NL) 2013-07-23 US disclosed
US-8492505-B2 Branched biodegradable polymers, a macromonomer, processes for the preparation of same, and their use UNIVERSITY OF TWENTE (NL) 2013-07-23 US disclosed
EP-2615138-A1 STEREOCOMPLEX POLYLACTIC ACID FILM AND RESIN COMPOSITION Teijin Limited (JP) 2013-07-17 EP disclosed
US-20130178567-A1 STEREOCOMPLEX POLYLACTIC ACID FILM AND RESIN COMPOSITION TEIJIN LIMITED (JP) 2013-07-11 US disclosed
US-20130164695-A1 METHOD FOR FORMING PATTERN JSR CORPORATION (JP) 2013-06-27 US disclosed
US-20130135384-A1 PHOTOCURABLE INK COMPOSITION FOR INK JET RECORDING SEIKO ESPON CORPORATION (JP) 2013-05-30 US disclosed
US-20130137252-A1 PATTERN FORMING METHOD CANON KABUSHIKI KAISHA (JP) 2013-05-30 US disclosed
US-20130136901-A1 CURABLE COMPOSITION AND METHOD OF FORMING PATTERN CANON KABUSHIKI KAISHA (JP) 2013-05-30 US disclosed
WO-2013066866-A1 ANTIBODY FORMULATIONS GENENTECH, INC. (US) 2013-05-10 WO disclosed
WO-2013062068-A1 METHOD OF FORMING FILM CANON KABUSHIKI KAISHA (JP) 2013-05-02 WO disclosed
EP-2585045-A2 COMPOSITIONS AND METHODS CONTAINING ALKYLGYCOSIDES FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS F.HOFFMANN-LA ROCHE AG (CH) 2013-05-01 EP disclosed
CN-103068367-A Compositions and methods comprising alkylglycosides for stabilizing protein-containing formulations GENENTECH INC 2013-04-24 CN disclosed
US-8420714-B2 Ink composition, and inkjet recording method FUJIFILM CORPORATION (JP) 2013-04-16 US disclosed
US-20130078232-A1 COMPOSITIONS AND METHODS USEFUL FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS GENENTECH, INC. (US) 2013-03-28 US disclosed
EP-2566510-A1 COMPOSITIONS AND METHODS USEFUL FOR REDUCING THE VISCOSITY OF PROTEIN-CONTAINING FORMULATIONS F. Hoffmann-La Roche AG (CH) 2013-03-13 EP disclosed
US-20130058958-A1 COMPOSITIONS AND METHODS USEFUL FOR REDUCING THE VISCOSITY OF PROTEIN-CONTAINING FORMULATIONS GENENTECH, INC. (US) 2013-03-07 US disclosed
EP-2563862-A1 CURABLE COMPOSITION Huntsman Advanced Materials (Switzerland) GmbH (CH) 2013-03-06 EP disclosed
CN-102958538-A Compositions and methods useful for reducing the viscosity of protein-containing formulations GENENTECH INC 2013-03-06 CN disclosed
US-8389630-B2 Curable composition KANEKA CORPORATION (JP) 2013-03-05 US disclosed
US-8383862-B2 Salt compound, cationic polymerization initiator and cationically polymerizable composition ADEKA CORPORATION (JP) 2013-02-26 US disclosed
US-20130045201-A1 METHODS OF USING ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION TO TREAT TUMOR IMMUNITY GENENTECH, INC. (US) 2013-02-21 US disclosed
US-20130045202-A1 ANTI-PD-L1 ANTIBODIES AND ARTICLES OF MANUFACTURE GENENTECH, INC. (US) 2013-02-21 US disclosed
US-20130045200-A1 METHODS OF USING ANTI-PD-L1 ANTIBODIES AND THEIR USE TO TREAT INFECTION RESULTING FROM T-CELL DYSFUNCTION GENENTECH, INC. (US) 2013-02-21 US disclosed
US-8377623-B2 Photocurable resin composition for producing three dimensional articles having high clarity 3D SYSTEMS, INC. (US) 2013-02-19 US disclosed
US-20130027488-A1 PRINTING METHOD, PRINTING DEVICE, PRINTED MATERIAL AND MOLDED ARTICLE SEIKO EPSON CORPORATION (JP) 2013-01-31 US disclosed
EP-2550018-A1 COMPOSITIONS AND METHODS USEFUL FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS F. Hoffmann-La Roche AG (CH) 2013-01-30 EP disclosed
EP-2551123-A2 Printing method, printing device, printed material and molded article Seiko Epson Corporation (JP) 2013-01-30 EP disclosed
EP-2223948-B1 SALT COMPOUND, CATIONIC POLYMERIZATION INITIATOR AND CATIONICALLY POLYMERIZABLE COMPOSITION ADEKA CORP (JP) 2013-01-23 EP disclosed
WO-2013006505-A1 USE OF ANTI-CD83 AGONIST ANTIBODIES FOR TREATING AUTOIMMUNE DISEASES GENENTECH, INC. (US) 2013-01-10 WO disclosed
US-8334025-B2 Antimony-free photocurable resin composition and three dimensional article 3D SYSTEMS, INC. (US) 2012-12-18 US disclosed
US-20120308791-A1 INK SET, PRINTED MATTER, AND MOLDED ARTICLE SEIKO EPSON CORPORATION (JP) 2012-12-06 US disclosed
EP-2524914-A1 NOVEL SULFONIC ACID DERIVATIVE COMPOUND AND NOVEL NAPHTHALIC ACID DERIVATIVE COMPOUND Adeka Corporation (JP) 2012-11-21 EP disclosed
US-20120288441-A1 INJECTABLE BIODEGRADABLE PARTICLES BOSTON SCIENTIFIC SCIMED, INC. (US) 2012-11-15 US disclosed
US-20120289697-A1 NOVEL SULFONIC ACID DERIVATIVE COMPOUND AND NOVEL NAPHTHALIC ACID DERIVATIVE COMPOUND ADEKA CORPORATION (JP) 2012-11-15 US disclosed
US-20120282439-A1 RADIATION CURABLE RESIN COMPOSITION AND RAPID THREE DIMENSIONAL IMAGING PROCESS USING THE SAME DSM IP ASSETS B.V. (NL) 2012-11-08 US disclosed
US-20120263926-A1 PRINTED MATERIAL AND METHOD FOR MANUFACTURING PRINTED MATERIAL SEIKO EPSON CORPORATION (JP) 2012-10-18 US disclosed
EP-2511101-A1 Printed material and method for manufacturing printed material Seiko Epson Corporation (JP) 2012-10-17 EP disclosed
US-8278030-B2 Sulfonium salt, photoacid generator, and photocurable composition and cured body thereof SAN-APRO LIMITED (JP) 2012-10-02 US disclosed
US-20120244478-A1 RESIST PATTERN FORMATION METHOD JSR CORPORATION (JP) 2012-09-27 US disclosed
US-8246998-B2 Injectable biodegradable particles BOSTON SCIENTIFIC SCIMED, INC. (US) 2012-08-21 US disclosed
US-8227624-B2 Aromatic sulfonium salt compound ADEKA CORPORATION (JP) 2012-07-24 US disclosed
US-20120178127-A1 Nucleic acid encoding apoptotic anti-ige antibodies GENENTECH, INC. (US) 2012-07-12 US disclosed
US-20120178020-A1 METHOD AND COMPOSITION FOR REDUCING WASTE IN PHOTO-IMAGING APPLICATIONS DSM IP ASSETS (NL) 2012-07-12 US disclosed
US-20120177635-A1 METHODS OF USING APOPTOTIC ANTI-IGE ANTIBODIES GENENTECH, INC. (US) 2012-07-12 US disclosed
US-8217149-B2 Anti-PD-L1 antibodies, compositions and articles of manufacture GENENTECH, INC. (US) 2012-07-10 US disclosed
US-20120172483-A1 PROCESS FOR PRODUCTION OF CURED MOLDED ARTICLE, AND CURED MOLDED ARTICLE NIPPON SHOKUBAI CO., LTD (JP) 2012-07-05 US disclosed
US-8211624-B2 Method for pattern formation and resin composition for use in the method JSR CORPORATION (JP) 2012-07-03 US disclosed
US-20120164395-A1 MANUFACTURING METHOD FOR PLASTIC MEMBER AND PLASTIC MEMBER CANON KABUSHIKI KAISHA (JP) 2012-06-28 US disclosed
US-8206894-B2 Resist pattern-forming method and resist pattern miniaturizing resin composition JSR CORPORATION (JP) 2012-06-26 US disclosed
US-20120156621-A1 RADIATION-SENSITIVE RESIN COMPOSITION JSR CORPORATION (JP) 2012-06-21 US disclosed
US-20120149881-A1 APOPTOTIC ANTI-IGE ANTIBODIES GENENTECH, INC. (US) 2012-06-14 US disclosed
US-8197053-B2 Active energy beam-curable ink and ink-jet recording method using active energy beam-curable ink BROTHER KOGYO KABUSHIKI KAISHA (JP) 2012-06-12 US disclosed
US-20120144512-A1 TRANSGENIC ANIMALS EXPRESSING HUMAN IGE-M1' GENENTECH, INC. (US) 2012-06-07 US disclosed
US-20120142806-A1 PHOTOSENSITIVE COMPOSITION SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2012-06-07 US disclosed
US-20120136155-A1 AROMATIC SULFONIUM SALT COMPOUND ADEKA CORPORATION (JP) 2012-05-31 US disclosed
US-20120130117-A1 AROMATIC SULFONIUM SALT COMPOUND ADEKA CORPORATION (JP) 2012-05-24 US disclosed
US-8173226-B2 Polymerizable compound , polyethylene glycol mono(meth)acrylate, a polystyrene oligomer having a methacryloyl group at one terminal, acrylic macromonomer imides FUJIFILM CORPORATION (JP) 2012-05-08 US disclosed
EP-2441778-A1 PHOTOSENSITIVE COMPOSITION Sanyo Chemical Industries, Ltd. (JP) 2012-04-18 EP disclosed
US-20120064086-A1 HIGH CONCENTRATION ANTIBODY AND PROTEIN FORMULATIONS NOVARTIS AG (CH) 2012-03-15 US disclosed
US-20120061864-A1 METHOD FOR MANUFACTURING LENS, APPARATUS FOR MANUFACTURING LENS, AND METHOD FOR MANUFACTURING OPTICAL APPARATUS CANON KABUSHIKI KAISHA (JP) 2012-03-15 US disclosed
EP-2138606-B1 A composition containing silica sol, its preparation method, and galvanized self-lubricating metal material using the composition PANGANG GROUP RES INST CO LTD (CN) 2012-02-08 EP disclosed
WO-2011163458-A2 COMPOSITIONS AND METHODS FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS GENENTECH, INC. (US) 2011-12-29 WO disclosed
EP-1970408-B1 CURABLE COMPOSITION KANEKA CORP (JP) 2011-12-28 EP disclosed
US-8071097-B2 Apoptotic anti-IgE antibodies GENENTECH, INC. (US) 2011-12-06 US disclosed
CN-102258464-A High concentration antibody and protein formulations 2011-11-30 CN disclosed
US-20110287236-A1 Ink Composition, Two-Pack Curing Ink Composition Set, and Recording Method and Recorded Matter Using These SEIKO EPSON CORPORATION (JP) 2011-11-24 US disclosed
US-8061830-B2 Ink-jet recording ink set and ink-jet recording method FUJIFILM CORPORATION (JP) 2011-11-22 US disclosed
CN-102245640-A Anti-PD-L1 antibodies and their use for enhancing T cell function HOFFMANN LA ROCHE 2011-11-16 CN disclosed
WO-2011139718-A1 COMPOSITIONS AND METHODS USEFUL FOR REDUCING THE VISCOSITY OF PROTEIN-CONTAINING FORMULATIONS GENENTECH, INC. (US) 2011-11-10 WO disclosed
WO-2011134686-A1 CURABLE COMPOSITION HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) 2011-11-03 WO disclosed
WO-2011133931-A1 USE OF IL-27 ANTAGONISTS FOR TREATING INFLAMMATORY BOWEL DISEASE GENENTECH, INC. (US) 2011-10-27 WO disclosed
EP-2376535-A1 ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION Genentech, Inc. (US) 2011-10-19 EP disclosed
US-8039542-B2 Pigment dispersion and ink composition using the same FUJIFILM CORPORATION (JP) 2011-10-18 US disclosed
WO-2011119487-A2 COMPOSITIONS AND METHODS USEFUL FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS GENENTECH, INC. (US) 2011-09-29 WO disclosed
US-8021471-B2 Modified colorants with aliphatic poly-acid groups CABOT CORPORATION (US) 2011-09-20 US disclosed
US-8021471-B2 Modified colorants with aliphatic poly-acid groups CABOT CORPORATION (US) 2011-09-20 US disclosed
US-20110223544-A1 RESIST PATTERN COATING AGENT AND RESIST PATTERN FORMING METHOD USING THE SAME JSR CORPORATION (JP) 2011-09-15 US disclosed
US-20110175089-A1 Dielectric Materials and Methods of Preparation and Use Thereof FLEXTERRA, INC. 2011-07-21 US disclosed
US-20110175089-A1 Dielectric Materials and Methods of Preparation and Use Thereof FLEXTERRA, INC. 2011-07-21 US disclosed
US-20110152540-A1 AROMATIC SULFONIUM SALT COMPOUND ADEKA CORPORATION (JP) 2011-06-23 US disclosed
EP-2335725-A1 High concentration antibody and protein formulations Genentech, Inc. (US) 2011-06-22 EP disclosed
US-20110136157-A1 Copper regulation evaluation and therapy PHILERA NEW ZEALAND LIMITED (NZ) 2011-06-09 US disclosed
US-20110123936-A1 RESIST PATTERN COATING AGENT AND RESIST PATTERN-FORMING METHOD JSR CORPORATION (JP) 2011-05-26 US disclosed
US-20110104500-A1 RADIATION CURABLE RESIN COMPOSITION AND RAPID THREE-DIMENSIONAL IMAGING PROCESS USING THE SAME STRATASYS INC. 2011-05-05 US disclosed
US-20110092643-A1 PROCESS FOR THE PREPARATION OF POLYCARBONATES STICHTING DUTCH POLYMER INSTITUTE (NL) 2011-04-21 US disclosed
US-7919545-B2 Pigment dispersion and ink composition using the same FUJIFILM CORPORATION (JP) 2011-04-05 US disclosed
WO-2011027845-A1 MANUFACTURING METHOD FOR PLASTIC MEMBER AND PLASTIC MEMBER CANON KABUSHIKI KAISHA (JP) 2011-03-10 WO disclosed
US-7901501-B2 Inkjet ink composition FUJIFILM CORPORATION (JP) 2011-03-08 US disclosed
US-20110039205-A1 SULFONIUM SALT, PHOTOACID GENERATOR, AND PHOTOCURABLE COMPOSITION AND CURED BODY THEREOF SAN-APRO LIMITED (JP) 2011-02-17 US disclosed
US-7888401-B2 Ink composition and inkjet ink, and image-forming method and recorded material using the same, and oxetane compound FUJIFILM CORPORATION (JP) 2011-02-15 US disclosed
US-20110027495-A1 PIGMENT DISPERSION, INK COMPOSITION, AND INKJET RECORDING METHOD FUJIFILM CORPORATION (JP) 2011-02-03 US disclosed
US-7878644-B2 Light cure of cationic ink on acidic substrates GERBER SCIENTIFIC INTERNATIONAL, INC. (US) 2011-02-01 US disclosed
US-20100323292-A1 RESIST PATTERN FORMATION METHOD, AND RESIN COMPOSITION CAPABLE OF INSOLUBILIZING RESIST PATTERN JSR CORPORATION (JP) 2010-12-23 US disclosed
US-20100319964-A1 CAST INSULATION RESIN FOR ELECTRIC APPARATUS AND HIGH VOLTAGE ELECTRIC APPARATUS USING THE SAME HITACHI INDUSTRIAL EQUIPMENT SYSTEMS CO., LTD. 2010-12-23 US disclosed
US-20100310988-A1 RESIST PATTERN-FORMING METHOD AND RESIST PATTERN MINIATURIZING RESIN COMPOSITION JSR CORPORATION (JP) 2010-12-09 US disclosed
US-20100304088-A1 RADIATION CURABLE RESIN COMPOSITION AND RAPID THREE DIMENSIONAL IMAGING PROCESS USING THE SAME STRATASYS INC. 2010-12-02 US disclosed
US-20100304100-A1 PHOTOCURABLE RESIN COMPOSITION FOR PRODUCING THREE DIMENSIONAL ARTICLES HAVING HIGH CLARITY HUNTSMAN ADVANCED MATERIALS AMERICAS LLC 2010-12-02 US disclosed
US-20100297127-A1 USE OF IL-27 ANTAGONISTS TO TREAT LUPUS F. HOFFMANN-LA ROCHE AG (CH) 2010-11-25 US disclosed
US-20100291017-A1 Hair Treatment Compositions CONOPCO, INC. D/B/A UNILEVER 2010-11-18 US disclosed
US-7834067-B2 Pigment composition, ink composition, printed article, inkjet recording method and polyallylamine derivative FUJIFILM CORPORATION (JP) 2010-11-16 US disclosed
US-20100266698-A1 USE OF INSULIN FOR THE TREATMENT OF CARTILAGINOUS DISORDERS GENENTECH, INC. (US) 2010-10-21 US disclosed
US-20100267857-A1 SALT COMPOUND, CATIONIC POLYMERIZATION INITIATOR AND CATIONICALLY POLYMERIZABLE COMPOSITION ADEKA CORPORATION (JP) 2010-10-21 US disclosed
EP-1867630-B1 PROCESS FOR PRODUCING TRICARBOXYLIC ACID TRIS(ALKYL-SUBSTITUTED CYCLOHEXYLAMIDE) NEW JAPAN CHEM CO LTD (JP) 2010-10-20 EP disclosed
US-7815303-B2 Inkjet recording method FUJIFILM CORPORATION (JP) 2010-10-19 US disclosed
WO-2010118243-A2 USE OF IL-27 ANTAGONISTS TO TREAT LUPUS GENENTECH, INC. (US) 2010-10-14 WO disclosed
US-20100230351-A1 Hydrophilic Membrane LYDALL SOLUTECH, B.V. (NL) 2010-09-16 US disclosed
US-20100227949-A1 CURABLE COMPOSITION KANEKA CORPORATION (JP) 2010-09-09 US disclosed
EP-1610820-B1 HIGH CONCENTRATION ANTIBODY AND PROTEIN FORMULATIONS GENENTECH INC (US) 2010-09-08 EP disclosed
EP-2223948-A1 SALT COMPOUND, CATIONIC POLYMERIZATION INITIATOR AND CATIONICALLY POLYMERIZABLE COMPOSITION Adeka Corporation (JP) 2010-09-01 EP disclosed
US-7781495-B2 Composition curable by radical photo curing and cationic photo curing in combination KANEKA CORPORATION (JP) 2010-08-24 US disclosed
EP-2217450-A1 PROCESSING OF LITHOGRAPHIC PRINTING PLATES WITH HYDROPHILIC POLYMER IN FINISHER SOLUTION Eastman Kodak Company (US) 2010-08-18 EP disclosed
US-20100203056-A1 ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION GENENTECH, INC. (US) 2010-08-12 US disclosed
US-20100203262-A1 INK COMPOSITION, AND INKJET RECORDING METHOD FUJIFILM CORPORATION (JP) 2010-08-12 US disclosed
US-20100201019-A1 Method and composition for reducing waste in photo-imaging applications DSM IP ASSETS B.V. 2010-08-12 US disclosed
EP-2215525-A1 PHOTOCURABLE RESIN COMPOSITION FOR PRODUCING THREE DIMENSIONAL ARTICLES HAVING HIGH CLARITY Huntsman Advanced Materials Americas LLC (US) 2010-08-11 EP disclosed
US-20100190104-A1 METHOD FOR PATTERN FORMATION AND RESIN COMPOSITION FOR USE IN THE METHOD JSR CORPORATION (JP) 2010-07-29 US disclosed
US-7763582-B2 Localized insulin delivery for bone healing UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 2010-07-27 US disclosed
EP-1770132-B1 Inkjet ink composition FUJIFILM CORP (JP) 2010-07-21 EP disclosed
WO-2010077634-A1 ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION GENENTECH, INC. (US) 2010-07-08 WO disclosed
US-7745661-B2 Process for producing tricarboxylic acid tris (alkyl-substituted cyclohexylamide) NEW JAPAN CHEMICAL CO., LTD. (JP) 2010-06-29 US disclosed
US-20100158898-A1 METHODS OF TREATING IgE-MEDIATED DISORDERS COMPRISING THE ADMINISTRATION OF HIGH CONCENTRATION ANTI-IgE ANTIBODY FORMULATIONS GENENTECH, INC. (US) 2010-06-24 US disclosed
WO-2010063763-A1 GUMMING COMPOSITIONS WITH NANO-PARTICLES FOR IMPROVING SCRATCH SENSITIVITY IN IMAGE AND NON-IMAGE AREAS OF LITHOGRAPHIC PRINTING PLATES EASTMAN KODAK COMPANY (US) 2010-06-10 WO disclosed
US-20100143606-A1 Photocation-Curable Ink and Ink-Jet Recording Method by Using Photocation-Curable Ink BROTHER KOGYO KABUSHIKI KAISHA (JP) 2010-06-10 US disclosed
US-20100137509-A1 PIGMENT DISPERSION AND INK COMPOSITION USING THE SAME FUJIFILM CORPORATION (JP) 2010-06-03 US disclosed
US-7723400-B2 Inkjet ink composition FUJIFILM CORPORATION (JP) 2010-05-25 US disclosed
EP-2186799-A1 AROMATIC SULFONIUM SALT COMPOUND Adeka Corporation (JP) 2010-05-19 EP disclosed
US-20100119835-A1 PHOTOCURABLE COMPOSITIONS FOR PREPARING ABS-LIKE ARTICLES HUNTSMAN INTERNATIONAL LLC (US) 2010-05-13 US disclosed
US-7703907-B2 Ink composition, inkjet-recording method and printed material FUJIFILM CORPORATION (JP) 2010-04-27 US disclosed
EP-1818373-B1 Inkjet ink composition comprising white hollow pigment FUJIFILM CORP (JP) 2010-04-14 EP disclosed
US-7696260-B2 Cationic compositions and methods of making and using the same DSM IP ASSETS B.V. (NL) 2010-04-13 US disclosed
US-20100079568-A1 Active Energy Beam-Curable Ink and Ink-Jet Recording Method Using Active Energy Beam-Curable Ink BROTHER KOGYO KABUSHIKI KAISHA (JP) 2010-04-01 US disclosed
US-20100081758-A1 PIGMENT DISPERSION AND INK COMPOSITION USING THE SAME FUJIFILM CORPORATION (JP) 2010-04-01 US disclosed
EP-1551890-B1 CURABLE COMPOSITIONS AND RAPID PROTOTYPING PROCESS USING THE SAME DSM IP ASSETS BV (NL) 2010-03-31 EP disclosed
CN-101679528-A Apoptotic anti-IgE antibodies that bind membrane-bound IgE GENENTECH INC 2010-03-24 CN disclosed
US-20100068650-A1 POSITIVE-WORKING RADIATION-SENSITIVE COMPOSITION AND METHOD FOR RESIST PATTERN FORMATION USING THE COMPOSITION JSR CORPORATION (JP) 2010-03-18 US disclosed
EP-1728811-B1 \"Branched biodegradable polymers, a macromonomer, processes for the preparation of same, and their use\ UNIV TWENTE (NL) 2010-02-24 EP disclosed
US-20100036036-A1 PHOTOCURABLE INK COMPOSITION FOR INK JET RECORDING SEIKO EPSON CORPORATION 2010-02-11 US disclosed
US-20100015408-A1 ANTIMONY-FREE PHOTOCURABLE RESIN COMPOSITION AND THREE DIMENSIONAL ARTICLE HUNTSMAN INTERNATIONAL LLC (US) 2010-01-21 US disclosed
US-7645036-B2 Ink-jet recording ink set and ink-jet recording method FUJIFILM CORPORATION (JP) 2010-01-12 US disclosed
US-20100001437-A1 METHOD AND COMPOSITION FOR REDUCING WASTE IN PHOTO-IMAGING APPLICATIONS DSM IP ASSETS B.V. (NL) 2010-01-07 US disclosed
EP-2137576-A1 DUAL PHOTOINITIATOR, PHOTOCURABLE COMPOSITION, USE THEREOF AND PROCESS FOR PRODUCING A THREE DIMENSIONAL ARTICLE Huntsman Advanced Materials Americas LLC (US) 2009-12-30 EP disclosed
EP-2138606-A1 A composition containing silica sol, its preparation method, and galvanized self-lubricating metal material using the composition PanGang Group Research Institute Co., Ltd. (CN) 2009-12-30 EP disclosed
EP-2132230-A2 APOPTOTIC ANTI-IGE ANTIBODIES BINDING THE MEMBRANE-BOUND IGE Genentech, Inc. (US) 2009-12-16 EP disclosed
EP-2118169-A1 CURABLE COMPOSITION Huntsman Advanced Materials (Switzerland) GmbH (CH) 2009-11-18 EP disclosed
US-20090280129-A1 HIGH CONCENTRATION ANTIBODY AND PROTEIN FORMULATIONS GENENTECH, INC. (US) 2009-11-12 US disclosed
US-20090263588-A1 PHOTOCURABLE COATING COMPOSITION, AND OVERPRINT AND PROCESS FOR PRODUCING SAME FUJIFILM CORPORATION (JP) 2009-10-22 US disclosed
US-20090234072-A1 CURABLE COMPOSITION KANEKA CORPORATION (JP) 2009-09-17 US disclosed
US-20090233062-A1 PIGMENT COMPOSITION, INK COMPOSITION, PRINTED ARTICLE, INKJET RECORDING METHOD AND POLYALLYLAMINE DERIVATIVE FUJIFILM CORPORATION (JP) 2009-09-17 US disclosed
US-20090226831-A1 PHOTOCURABLE COATING COMPOSITION, AND OVERPRINT AND PROCESS FOR PRODUCING SAME FUJIFILM CORPORATION (JP) 2009-09-10 US disclosed
US-20090220877-A1 PHOTOCURABLE COMPOSITION, OVERPRINT, AND PRODUCTION PROCESS THEREFOR FUJIFILM CORPORATION (JP) 2009-09-03 US disclosed
US-20090214468-A1 Localized Insulin Delivery for Bone Healing THE UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 2009-08-27 US disclosed
US-20090214797-A1 INKJET INK COMPOSITION, AND INKJET RECORDING METHOD AND PRINTED MATERIAL EMPLOYING SAME FUJIFILM CORPORATION (JP) 2009-08-27 US disclosed
US-7576142-B2 Polyorganosiloxane and curable composition containing same TOAGOSEI CO., LTD. (JP) 2009-08-18 US disclosed
US-20090170975-A1 PHOTORADICAL- AND PHOTOCATION-CURABLE COMPOSITION KANEKA CORPORATION (JP) 2009-07-02 US disclosed
US-7551811-B2 Optical device and method for producing the same BRIDGESTONE CORPORATION (JP) 2009-06-23 US disclosed
WO-2009070500-A1 PHOTOCURABLE RESIN COMPOSITION FOR PRODUCING THREE DIMENSIONAL ARTICLES HAVING HIGH CLARITY HUNTSMAN ADVANCED MATERIALS AMERICAS INC. (US) 2009-06-04 WO disclosed
WO-2009065849-A1 PROCESSING OF LITHOGRAPHIC PRINTING PLATES WITH HYDROPHILIC POLYMER IN FINISHER SOLUTION EASTMAN KODAK COMPANY (US) 2009-05-28 WO disclosed
US-20090117033-A1 INJECTABLE BIODEGRADABLE PARTICLES BOSTON SCIENTIFIC SCIMED, INC. (US) 2009-05-07 US disclosed
US-20090118459-A1 BRANCHED BIODEGRADABLE POLYMERS, A MACROMONOMER, PROCESSES FOR THE PREPARATION OF SAME, AND THEIR USE UNIVERSITY OF TWENTE (NL) 2009-05-07 US disclosed
US-20090118459-A1 BRANCHED BIODEGRADABLE POLYMERS, A MACROMONOMER, PROCESSES FOR THE PREPARATION OF SAME, AND THEIR USE UNIVERSITY OF TWENTE (NL) 2009-05-07 US disclosed
US-20090118459-A1 BRANCHED BIODEGRADABLE POLYMERS, A MACROMONOMER, PROCESSES FOR THE PREPARATION OF SAME, AND THEIR USE UNIVERSITY OF TWENTE (NL) 2009-05-07 US disclosed
EP-1775317-B1 POLYORGANOSILOXANE AND CURABLE COMPOSITION CONTAINING SAME TOAGOSEI CO LTD (JP) 2009-04-15 EP disclosed
US-20090093542-A1 Copper antagonist compositions COOPER GARTH J S 2009-04-09 US disclosed
US-20090093506-A1 Copper antagonist compositions COOPER GARTH J S 2009-04-09 US disclosed
US-20090085996-A1 INKJET RECORDING METHOD FUJIFILM CORPORATION (JP) 2009-04-02 US disclosed
EP-1877801-A4 COPPER REGULATION EVALUATION AND THERAPY PROTEMIX CORP LTD (NZ) 2009-03-18 EP disclosed
US-20090069599-A1 PROCESS FOR PRODUCING TRICARBOXYLIC ACID TRIS (ALKYL-SUBSTITUTED CYCLOHEXYLAMIDE) NEW JAPAN CHEMICAL CO., LTD., (JP) 2009-03-12 US disclosed
CN-101370472-A Hair treatment compositions UNILEVER PLC (NL) 2009-02-18 CN disclosed
US-20090010924-A1 Apoptotic Anti-IgE Antibodies GENENTECH, INC. (US) 2009-01-08 US disclosed
US-20090004579-A1 Clear and colorless three-dimensional articles made via stereolithography and method of making said articles DSM IP ASSETS B.V. (NL) 2009-01-01 US disclosed
EP-2005246-A1 CATIONIC COMPOSITION AND METHODS OF MAKING AND USING THE SAME DSMIP Assets B.V. (NL) 2008-12-24 EP disclosed
US-20080286450-A1 hazardous waste reduction in stereolithography; nonhazardous: photosensitizer 4-benzoyl-4-methyldiphenyl sulfide, photoacid diffusion inhibitor, an oxetane, and boron containing cationic photoinitiator; antimony-free DSM IP ASSETS B.V. (NL) 2008-11-20 US disclosed
WO-2008127930-A1 DUAL PHOTOINITIATOR, PHOTOCURABLE COMPOSITION, USE THEREOF AND PROCESS FOR PRODUCING A THREE DIMENSIONAL ARTICLE HUNTSMAN ADVANCED MATERIALS AMERICAS INC. 2008-10-23 WO disclosed
US-20080241416-A1 POLYMERIZABLE COMPOUND, POLYMER, INK COMPOSITION, PRINTED ARTICLES AND INKJET RECORDING METHOD FUJIFILM CORPORATION (JP) 2008-10-02 US disclosed
US-20080241485-A1 INK COMPOSITION AND IMAGE RECORDING METHOD AND IMAGE RECORDED MATTER USING SAME FUJIFILM CORPORATION (JP) 2008-10-02 US disclosed
WO-2008116149-A2 APOPTOTIC ANTI- IGE ANTIBODIES BINDING THE MEMBRANE-BOUND IGE GENENTECH, INC. (US) 2008-09-25 WO disclosed
WO-2008110564-A1 CURABLE COMPOSITION HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) 2008-09-18 WO disclosed
EP-1970408-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2008-09-17 EP disclosed
EP-1959917-A1 HAIR TREATMENT COMPOSITIONS UNILEVER PLC (GB) 2008-08-27 EP disclosed
EP-1237575-B1 TNF-ALPHA ANTAGONIST AND LFA-1 ANTAGONIST FOR TREATING RHEUMATOID ARTHRITIS GENENTECH INC (US) 2008-08-06 EP disclosed
EP-1941322-A1 ANTIMONY-FREE PHOTOCURABLE RESIN COMPOSITION AND THREE DIMENSIONAL ARTICLE Huntsman Advanced Materials (Switzerland) GmbH (CH) 2008-07-09 EP disclosed
US-20080132599-A1 Ink composition, two-pack curing ink composition set, and recording method and recorded matter using these SEIKO EPSON CORPORATION. 2008-06-05 US disclosed
EP-1927633-A1 Ink composition, two-pack curing ink composition set, and recording method and recorded matter using these Seiko Epson Corporation (JP) 2008-06-04 EP disclosed
EP-1918337-A1 Ink set SEIKO EPSON CORPORATION (JP) 2008-05-07 EP disclosed
US-20080103226-A1 Photo-curable resin composition DSM IP ASSETS B.V. (NL) 2008-05-01 US disclosed
EP-0779806-B2 SUSTAINED RELEASE PREPARATION CONTAINING METAL SALT OF A PEPTIDE TAKEDA PHARMACEUTICAL (JP) 2008-04-16 EP disclosed
US-20080083347-A1 Readily dispersible in liquid vehicles; stability; ink jet pigments; quality optical density on plain paper CABOT CORPORATION 2008-04-10 US disclosed
US-20080083347-A1 Readily dispersible in liquid vehicles; stability; ink jet pigments; quality optical density on plain paper CABOT CORPORATION 2008-04-10 US disclosed
US-20080031875-A1 TREATMENT METHOD GENENTECH, INC. (US) 2008-02-07 US disclosed
US-20080033137-A1 Polyorganosiloxane And Curable Composition Containing Same TOAGOSEI CO., LTD. (JP) 2008-02-07 US disclosed
US-20080033072-A1 Ink composition and inkjet ink, and image-forming method and recorded material using the same, and oxetane compound FUJIFILM CORPORATION (JP) 2008-02-07 US disclosed
EP-1877801-A1 COPPER REGULATION EVALUATION AND THERAPY Protemix Corporation Limited (NZ) 2008-01-16 EP disclosed
EP-1282605-B1 THIOIMIDAZOLIDINE DERIVATIVES AS LIGHT STABILISERS FOR POLYMERS CIBA SC HOLDING AG (CH) 2008-01-02 EP disclosed
EP-1867630-A1 PROCESS FOR PRODUCING TRICARBOXYLIC ACID TRIS(ALKYL-SUBSTITUTED CYCLOHEXYLAMIDE) NEW JAPAN CHEMICAL CO.,LTD. (JP) 2007-12-19 EP disclosed
US-7294344-B2 Sustained-release preparation for AII antagonist, production and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-11-13 US disclosed
US-20070259287-A1 Resin Composition for Forming Fine Pattern and Method for Forming Fine Pattern JSR CORPORATION (JP) 2007-11-08 US disclosed
WO-2007112921-A1 CATIONIC COMPOSITION AND METHODS OF MAKING AND USING THE SAME DSM IP ASSETS B.V. (NL) 2007-10-11 WO disclosed
US-20070228614-A1 Cationic compositions and methods of making and using the same DSM IP ASSETS B.V. (NL) 2007-10-04 US disclosed
US-20070216743-A1 Ink-jet recording ink set and ink-jet recording method FUJIFILM CORPORATION (JP) 2007-09-20 US disclosed
US-7268112-B2 Use of insulin for the treatment of cartilaginous disorders GENETECH, INC. (US) 2007-09-11 US disclosed
US-20070208098-A1 Composition Curable By Radical Photo Curing And Cationic Photo Curing In Combination KANEKA CORPORATION (JP) 2007-09-06 US disclosed
US-20070206045-A1 Ink-jet recording ink set and ink-jet recording method FUJI PHOTO FILM CO., LTD. (JP) 2007-09-06 US disclosed
WO-2007098479-A2 LOCALIZED INSULIN DELIVERY FOR BONE HEALING UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 2007-08-30 WO disclosed
US-20070191509-A1 Ink jet composition FUJIFILM CORPORATION (JP) 2007-08-16 US disclosed
EP-1818373-A2 Inkjet ink composition comprising a hollow white pigment particle FUJIFILM Corporation (JP) 2007-08-15 EP disclosed
US-7252865-B2 Protective films containing compatible plasticizer compounds useful in polarizing plates for displays and their method of manufacture EASTMAN KODAK COMPANY (US) 2007-08-07 US disclosed
US-20070149667-A1 Curable compositions and rapid prototyping process using the same DSM IP ASSETS B.V. (NL) 2007-06-28 US disclosed
WO-2007068399-A1 HAIR TREATMENT COMPOSITIONS UNILEVER PLC (GB) 2007-06-21 WO disclosed
US-20070110958-A1 Light cure of cationic ink on acidic substrates GERBER SCIENTIFIC, INC. 2007-05-17 US disclosed
WO-2007048819-A1 ANTIMONY-FREE PHOTOCURABLE RESIN COMPOSITION AND THREE DIMENSIONAL ARTICLE HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) 2007-05-03 WO disclosed
US-20070086995-A1 Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations GENENTECH, INC. (US) 2007-04-19 US disclosed
EP-1775317-A1 POLYORGANOSILOXANE AND CURABLE COMPOSITION CONTAINING SAME TOAGOSEI CO., LTD. (JP) 2007-04-18 EP disclosed
US-20070078195-A1 Inkjet ink composition FUJI PHOTO FILM CO., LTD. 2007-04-05 US disclosed
EP-1770132-A1 Inkjet ink composition FUJIFILM Corporation (JP) 2007-04-04 EP disclosed
US-20070053900-A1 HIGH CONCENTRATION ANTIBODY AND PROTEIN FORMULATIONS GENENTECH, INC. (US) 2007-03-08 US disclosed
US-20070049516-A1 Use of Insulin for the Treatment of Cartilaginous Disorders GENENTECH, INC. 2007-03-01 US disclosed
US-20070043138-A1 Resin composition for photofabrication of three dimensional objects YAMAMURA TETSUYA 2007-02-22 US disclosed
US-7163701-B2 Controlled release microencapsulated NGF formulation GENENTECH, INC. (US) 2007-01-16 US disclosed
US-7153973-B2 Imidazolidinone derivatives CIBA SPECIALTY CHEMICALS CORPORATION (US) 2006-12-26 US disclosed
WO-2006128704-A1 BRANCHED BIODEGRADABLE POLYMERS, A MACROMONOMER, PROCESSES FOR THE PREPARATION OF SAME, AND THEIR USE UNIVERSITY OF TWENTE (NL) 2006-12-07 WO disclosed
EP-1728811-A1 \"Branched biodegradable polymers, a macromonomer, processes for the preparation of same, and their use\ University of Twente (NL) 2006-12-06 EP disclosed
WO-2006115421-A1 COPPER REGULATION EVALUATION AND THERAPY PROTEMIX CORPORATION LIMITED (NZ) 2006-11-02 WO disclosed
US-20060231982-A1 Viscosity reducible radiation curable resin composition DSM IP ASSETS B.V. (NL) 2006-10-19 US disclosed
WO-2006104398-A1 COPPER ANTAGONIST COMPOSITIONS PROTEMIX CORPORATION LIMITED (NZ) 2006-10-05 WO disclosed
WO-2006104397-A1 COPPER ANTAGONIST COMPOSITIONS PROTEMIX CORPORATION LIMITED (NZ) 2006-10-05 WO disclosed
WO-2006104400-A1 COPPER ANTAGONIST COMPOSITIONS PROTEMIX CORPORATION LIMITED (NZ) 2006-10-05 WO disclosed
WO-2006104396-A1 PRE-COMPLEXED COPPER ANTAGONIST COMPOSITIONS PROTEMIX CORPORATION LIMITED (NZ) 2006-10-05 WO disclosed
WO-2006104401-A1 COPPER ANTAGONIST COMPOSITIONS PROTEMIX CORPORATION LIMITED (NZ) 2006-10-05 WO disclosed
WO-2006104399-A1 COPPER ANTAGONIST COMPOSITIONS PROTEMIX CORPORATION LIMITED (NZ) 2006-10-05 WO disclosed
US-20060222832-A1 Ink composition, inkjet-recording method and printed material FUJI PHOTO FILM CO., LTD. 2006-10-05 US disclosed
WO-2006104402-A1 COPPER ANTAGONIST COMPOSITIONS PROTEMIX CORPORATION LIMITED (NZ) 2006-10-05 WO disclosed
US-20060194029-A1 Ink composition, inkjet recording method using the same, and printed material FUJI PHOTO FILM CO., LTD. 2006-08-31 US disclosed
WO-2006082103-A2 NOVEL CATIONlC COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME DSM IP ASSETS B.V. (NL) 2006-08-10 WO disclosed
US-20060171627-A1 Optical device and method for producing the same BRIDGESTONE CORPORATION 2006-08-03 US disclosed
US-20060172230-A1 hazardous waste reduction in stereolithography; nonhazardous: photosensitizer 4-benzoyl-4-methyldiphenyl sulfide, photoacid diffusion inhibitor, an oxetane, and boron containing cationic photoinitiator; fluorinated surfactants or polymers increase curing rate; antimony-free DSM IP ASSETS B.V. (NL) 2006-08-03 US disclosed
CN-1267289-C Front body of flat printing plate FUJI PHOTO FILM CO LTD (JP) 2006-08-02 CN disclosed
CN-1798575-A High concentration antibody and protein formulations GENENTECH INC (US) 2006-07-05 CN disclosed
WO-2006065746-A2 METHODS OF TREATING IGE-MEDIATED DISORDERS COMPRISING THE ADMINISTRATION OF HIGH CONCENTRATION ANTI-IGE ANTIBODY FORMULATIONS GENENTECH, INC. (US) 2006-06-22 WO disclosed
EP-1265630-B1 USE OF INSULIN FOR THE TREATMENT OF CARTILAGENOUS DISORDERS GENENTECH INC (US) 2006-06-07 EP disclosed
US-20060094833-A1 Shock resistant cyanoacrylate compositions LOCTITE (R&D) LIMITED 2006-05-04 US disclosed
WO-2006033824-A1 COMPATIBLE PLASTICIZER COMPOUNDS USEFUL IN POLARIZING PLATES EASTMAN KODAK COMPANY (US) 2006-03-30 WO disclosed
US-20060062933-A1 Protective films containing compatible plasticizer compounds useful in polarizing plates for displays and their method of manufacture EASTMAN KODAK COMPANY 2006-03-23 US disclosed
EP-1610820-A1 HIGH CONCENTRATION ANTIBODY AND PROTEIN FORMULATIONS Genentech, Inc. (US) 2006-01-04 EP disclosed
US-20050287470-A1 Curable compositions and rapid prototyping process using the same DSM IP ASSETS B.V. (NL) 2005-12-29 US disclosed
US-20050214291-A1 Treatment method GENENTECH, INC. (US) 2005-09-29 US disclosed
US-20050171255-A1 Resin composition for photofabrication of three dimensional objects YAMAMURA TETSUYA (JP) 2005-08-04 US disclosed
US-6924330-B2 Thioimidazolidine derivatives as light stabilizers for polymers CIBA SPECIALTY CHEMICALS CORP. (US) 2005-08-02 US disclosed
US-20050158303-A1 Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations GENENTECH, INC. 2005-07-21 US disclosed
US-6866376-B2 Active energy beam-curable composition, ink containing the same, and printer accommodating the same ink BROTHER KOGYO KABUSHIKI KAISHA (JP) 2005-03-15 US disclosed
US-20050038236-A1 Imidazolidinone derivatives LAZZARI DARIO (IT) 2005-02-17 US disclosed
US-20040219208-A1 Sustained-release medicines TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-11-04 US disclosed
WO-2004091658-A1 HIGH CONCENTRATION ANTIBODY AND PROTEIN FORMULATIONS GENENTECH, INC. (US) 2004-10-28 WO disclosed
US-6805439-B2 Active energy beam-curable composition, ink containing the same, and printer accommodating the same ink BROTHER KOGYO KABUSHIKI KAISHA (JP) 2004-10-19 US disclosed
US-20040197324-A1 High concentration antibody and protein formulations GENENTECH, INC. 2004-10-07 US disclosed
EP-1001814-B1 CONTROLLED RELEASE MICROENCAPSULATED NGF FORMULATION GENENTECH INC (US) 2004-09-15 EP disclosed
US-20040138101-A1 Use of insulin for the treatment of cartilaginous disorders GENENTECH, INC. 2004-07-15 US disclosed
US-20040121008-A1 Process for producing sustained release preparation TAKEDA PHARMACEUTICAL COMPANY (JP) 2004-06-24 US disclosed
EP-0835101-B1 METHOD OF PRODUCING SUSTAINED-RELEASE PREPARATION TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-06-09 EP disclosed
EP-1413315-A1 SUSTAINED-RELEASE MEDICINES Takeda Chemical Industries, Ltd. (JP) 2004-04-28 EP disclosed
US-6689747-B2 ESPECIALLY ADMINISTERED BY DIRECT INJECTION INTO THE AFFLICTED CARTILAGENOUS REGION OR JOINT. GENENTECH, INC. 2004-02-10 US disclosed
US-6685869-B2 PHOTOCURING USING PHOTOINITIATOR; IMPACT STRENGTH DSM N.V. (NL) 2004-02-03 US disclosed
EP-1058541-B1 SUSTAINED-RELEASE PREPARATION FOR AII ANTAGONIST, PRODUCTION AND USE THEREOF TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-01-28 EP disclosed
US-6663899-B2 Nerve growth factor GENENTECH, INC. 2003-12-16 US disclosed
EP-1369130-A1 PROCESS FOR PRODUCING SUSTAINED RELEASE PREPARATION Takeda Chemical Industries, Ltd. (JP) 2003-12-10 EP disclosed
CN-1129478-C Esterification catalysts ACMA LTD (GB) 2003-12-03 CN disclosed
US-20030203040-A1 Controlled release microencapsulated NGF formulation CLELAND JEFFREY L (US) 2003-10-30 US disclosed
US-20030198676-A1 Sustained-release preparation for AII antagonist, production and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-23 US disclosed
US-20030189192-A1 Stabilizing mixtures for organic polymers GREAT LAKES CHEMICAL (EUROPE) GMBH (CH) 2003-10-09 US disclosed
CN-1444920-A Emusification cosmetic material FUJIXEROX CO LTD (JP) 2003-10-01 CN disclosed
US-20030112307-A1 Active energy beam-curable composition, ink containing the same, and printer accommodating the same ink BROTHER KOGYO KABUSHIKI KAISHA (JP) 2003-06-19 US disclosed
US-20030109609-A1 Thioimidazolidine derivatives as light stabilizers for polymers CIBA SPECIALTY CHEMICALS CORP. 2003-06-12 US disclosed
US-6555603-B1 Addition of a nitroxy compound to a low density polymer ASAHI DENKA KOGYO K.K. (JP) 2003-04-29 US disclosed
US-20030073835-A1 Light, heat and oxidation resistance; stabilizers CIBA SPECIALTY CHEMICALS CORP. 2003-04-17 US disclosed
US-20030068374-A1 Sustained release preparations of physiologically active compound hardly soluble in water and production process and use of the same TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-04-10 US disclosed
CN-1409639-A TNF-alpha antagonist and LFA-1 antagonist for treating LFA-1 or TNF-alpha mediated disorder GENENTECH INC (US) 2003-04-09 CN disclosed
US-20030064912-A1 Pharmaceutical compositions and methods of inhibiting angiogenesis using NAALADase inhibitors SLUSHER BARBARA S (US) 2003-04-03 US disclosed
US-20030059708-A1 Resin composition and three-dimensional object DSM IP ASSETS B.V. (NL) 2003-03-27 US disclosed
CN-1405014-A Front body of flat printing plate FUJI PHOTO FILM CO LTD (JP) 2003-03-26 CN disclosed
EP-1283240-A1 Imidazolidinone derivatives Ciba SC Holding AG (CH) 2003-02-12 EP disclosed
EP-1282605-A2 THIOIMIDAZOLIDINE DERIVATIVES AS LIGHT STABILISERS FOR POLYMERS Ciba SC Holding AG (CH) 2003-02-12 EP disclosed
EP-1268633-A1 STABILIZING MIXTURES FOR ORGANIC POLYMERS Great Lakes Chemical (Europe) GmbH (CH) 2003-01-02 EP disclosed
EP-1265630-A2 USE OF INSULIN FOR THE TREATMENT OF CARTILAGENOUS DISORDERS Genentech, Inc. (US) 2002-12-18 EP disclosed
EP-0889722-B1 SUSTAINED-RELEASE PREPARATION AND ITS PRODUCTION TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2002-11-20 EP disclosed
EP-1258254-A1 SUSTAINED RELEASE PREPARATIONS OF PHYSIOLOGICALLY ACTIVE COMPOUND HARDLY SOLUBLE IN WATER AND PRODUCTION PROCESS AND USE OF THE SAME Takeda Chemical Industries, Ltd. (JP) 2002-11-20 EP disclosed
US-20020168337-A1 Sustained-release preparation TAKADA CHEMICAL INDUSTRIES LTD. 2002-11-14 US disclosed
EP-0973731-B1 HYDROXAMIC ACID DERIVATIVES GUILFORD PHARM INC (US) 2002-08-28 EP disclosed
US-6429296-B2 DISPERSING A COMPLEX OF HUMAN GROWTH HORMONE AND ZINC CONTAINING HUMAN GROWTH HORMONE AND ZINC AT A MOLAR RATIO 1:1.6 TO 1:2.4 IN OIL PHASE CONTAINING BIODEGRADABLE POLYMER TO MAKE SOLID-IN-OIL EMULSION, ADDING WATER, IN-WATER TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-08-06 US disclosed
CN-1351520-A Esterification catalysts ACMA LTD (GB) 2002-05-29 CN disclosed
US-6395718-B1 RHEUMATIC DISEASES; ANTIARTHRITIC AGENTS; CARDIOVASCULAR DISORDERS GUILFORD PHARMACEUTICALS INC. 2002-05-28 US disclosed
US-20020058622-A1 Sustained-release preparation IGARI YASUTAKA (JP) 2002-05-16 US disclosed
US-20020058614-A1 Use of insulin for the treatment of cartilagenous disorders GENENTECH, INC. 2002-05-16 US disclosed
US-6376461-B1 WATER INSOLUBLE OR SLIGHTLY WATER SOLUBLE POLYVALENT METAL SALT OF A GROWTH HORMONE, AND A BIODEGRADABLE POLYMER; ENDOTHELIN ANTAGONIST TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-04-23 US disclosed
CN-1334860-A Bleaching compositions PROCTER & GAMBLE (US) 2002-02-06 CN disclosed
US-20020004481-A1 CONTROLLED RELEASE MICROENCAPSULATED NGF FORMULATION GENENTECH, INC. 2002-01-10 US disclosed
US-20010044459-A1 Hydroxamic acid derivatives JACKSON PAUL F (US) 2001-11-22 US disclosed
EP-1156083-A1 RESIN COMPOSITION FOR AGRICULTURAL FILM ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 2001-11-21 EP disclosed
US-20010031260-A1 Treatment method GENENTECH, INC. 2001-10-18 US disclosed
WO-2001072323-A2 USE OF INSULIN FOR THE TREATMENT OF CARTILAGENOUS DISORDERS GENENTECH, INC. (US) 2001-10-04 WO disclosed
WO-2001070868-A1 STABLILIZING MIXTURES FOR ORGANIC POLYMERS GREAT LAKES CHEMICAL (EUROPE) GMBH (CH) 2001-09-27 WO disclosed
WO-2001062739-A2 THIOIMIDAZOLIDINE DERIVATIVES AS LIGHT STABILIZERS FOR POLYMERS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2001-08-30 WO disclosed
US-6271245-B1 INHIBITORS OF N-ACETYLATED ALPHA-LINKED ACIDIC DIPEPTIDASE (NAALADASE) ENZYME FOR TREATING GLUTAMATE ABNORMALITY (EPILEPSY, STROKE, ALZHEIMER'S DISEASE, SCHIZOPHRENIA, PAIN, ISCHMIA, PARKINSON'S AND HUNTINGTON'S) AND PROSTATE CANCER GUILFORD PHARMACEUTICALS, INC. 2001-08-07 US disclosed
US-6267981-B1 DISPERSING BIOACTIVE POLYPEPTIDE IN ORGANIC SOLVENT CONTAINING METAL SALT OF BIODEGRADABLE POLYMER, REMOVING ORGANIC SOLVENT FROM RESULTING DISPERSION TO FORM PARTICULATE ARTIFACT TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-07-31 US disclosed
US-20010006678-A1 Sustained-release material prepared by dispersing a lyophilized polypeptide in an oil phase TAKADA SHIGEYUKI (JP) 2001-07-05 US disclosed
US-20010002263-A1 Complex of human growth hormone and zinc and use YAMAGATA YUTAKA (JP) 2001-05-31 US disclosed
US-6190702-B1 LYOPHILIZING AN ADMIXTURE OF A BIOACTIVE POLYPEPTIDE SUCH AS HORMONE OR CYTOKINE AND A NON-IONIC SURFACTANT TO OBTAIN A LYOPHILIZED PRODUCT; DISPERSING AS A SOLID PHASE IN AN OIL IN WATER-TYPE EMULSION; SHAPING RESULTING DISPERSION TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-02-20 US disclosed
US-6191107-B1 COMPLEXES WITH BIODREGADABLE POLYMERS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-02-20 US disclosed
EP-1058541-A1 SUSTAINED-RELEASE PREPARATION FOR AII ANTAGONIST, PRODUCTION AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2000-12-13 EP disclosed
EP-0779806-B1 SUSTAINED RELEASE PREPARATION CONTAINING METAL SALT OF A PEPTIDE TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2000-11-08 EP disclosed
US-6113947-A METALS AND NGF GENENTECH, INC. (US) 2000-09-05 US disclosed
CN-1054616-C Dicyclohexyl-3,4,3',4'-tetracarboxylic acid or dianhydride thereof and polyamide-acid and polyimide obtained therefrom HITACHI CHEMICAL CO LTD (JP) 2000-07-19 CN disclosed
US-6087324-A A WATER-INSOLUBLE OR A SLIGHTLY WATER-SOLUBLE POLYVALENT METAL SALT OF A WATER-SOLUBLE PHYSIOGICALLY ACTIVE PEPTIDE WHICH IS NOT AN ENDOTHELIN ANTAGONIST, AND A BIODEGRADABLE POLYMER SUCH AS COPOLYMER OF GLYCOLIC AND LACTIC ACID TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-07-11 US disclosed
CN-1258015-A Oriented film prepared from polyimide and liquid crystal display contg. same HITACHI KASEI CO LTD (JP) 2000-06-28 CN disclosed
EP-1002529-A1 Sustained-release preparation containing a metal salt of a peptide Takeda Chemical Industries, Ltd. (JP) 2000-05-24 EP disclosed
EP-1001814-A1 CONTROLLED RELEASE MICROENCAPSULATED NGF FORMULATION Genentech, Inc. (US) 2000-05-24 EP disclosed
US-5962521-A PROSTATE GLANDS DISORDERS GUILFORD PHARMACEUTICALS INC. (US) 1999-10-05 US disclosed
EP-0633020-B1 Method of producing sustained-release preparation TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1999-09-15 EP disclosed
WO-1999044590-A1 SUSTAINED-RELEASE PREPARATION FOR AII ANTAGONIST, PRODUCTION AND USE THEREOF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-09-10 WO disclosed
EP-0905143-A2 Complex of human growth hormone and zinc and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-03-31 EP disclosed
EP-0896642-A1 PROCESS FOR THE PREPARATION OF TETRAALKYL 1,2,3,4-BUTANETETRACARBOXYLATES MONSANTO COMPANY (US) 1999-02-17 EP disclosed
EP-0617336-B1 Electrostatic image developer NEC CORP (JP) 1999-01-13 EP disclosed
EP-0889722-A2 SUSTAINED-RELEASE PREPARATION AND ITS PRODUCTION Takeda Chemical Industries, Ltd. (JP) 1999-01-13 EP disclosed
WO-1998057654-A1 METHODS FOR TREATMENT OF OCULAR NEOVASCULARIZATION JOHNS HOPKINS UNIVERSITY (US) 1998-12-23 WO disclosed
WO-1998056426-A1 CONTROLLED RELEASE MICROENCAPSULATED NGF FORMULATION GENENTECH, INC. (US) 1998-12-17 WO disclosed
EP-0882091-A1 UNSATURATED POLYESTER RESINS FLAME RETARDED BY MELAMINE AND PHOSPHORUS COMPOUNDS DSM N.V. (NL) 1998-12-09 EP disclosed
US-5840338-A THERMAL AND CHEMICAL STABILITY MEDLOGIC GLOBAL LIMITED (GB) 1998-11-24 US disclosed
EP-0872504-A1 CURABLE EPOXY RESIN COMPOSITION WHICH GIVES FLEXIBLE CURED ARTICLE ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1998-10-21 EP disclosed
EP-0870790-A1 CURABLE EPOXY RESIN COMPOSITION ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1998-10-14 EP disclosed
EP-0412588-B1 Epoxy prepreg LIGUSTICA S A (CH) 1998-10-07 EP disclosed
JP-H10140196-A DETERGENT COMPOSITION FOR HEAT EXCHANGER FIN NOF CORP 1998-05-26 JP disclosed
EP-0835101-A2 METHOD OF PRODUCING SUSTAINED-RELEASE PREPARATION Takeda Chemical Industries, Ltd. (JP) 1998-04-15 EP disclosed
EP-0547578-B1 Light-sensitive composition FUJI PHOTO FILM CO LTD (JP) 1998-03-18 EP disclosed
EP-0818423-A1 Scale inhibition process FMC CORPORATION (UK) LIMITED (GB) 1998-01-14 EP disclosed
US-5696261-A Piperidine-triazine compounds suitable for use as stabilisers for organic materials CIBA SPECIALTY CHEMICALS CORPORATION (US) 1997-12-09 US disclosed
WO-1997035563-A2 SUSTAINED-RELEASE PREPARATION AND ITS PRODUCTION TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-10-02 WO disclosed
EP-0798321-A2 Epoxy prepreg Ligustica S.A. (CH) 1997-10-01 EP disclosed
WO-1997031056-A1 UNSATURATED POLYESTER RESINS FLAME RETARDED BY MELAMINE AND PHOSPHORUS COMPOUNDS DSM N.V. (NL) 1997-08-28 WO disclosed
CN-1157562-A Sustained release preparation containing a peptide metal salt TAKEDA CHEMICAL INDUSTIRES LTD (JP) 1997-08-20 CN disclosed
EP-0779806-A1 SUSTAINED RELEASE PREPARATION CONTAINING METAL SALT OF A PEPTIDE Takeda Chemical Industries, Ltd. (JP) 1997-06-25 EP disclosed
EP-0354184-B1 Compounds containing substituted piperidine groups for use as stabilizers for organic materials CIBA GEIGY AG (CH) 1997-02-26 EP disclosed
EP-0517658-B1 Stabilisation of polymeric organic materials by using synergistic mixtures comprising sterically hindered cyclic amines and derivatives of 3-pyrazolidinone or 1,2,4-triazolidine-3,5-dione CIBA GEIGY AG (CH) 1997-01-29 EP disclosed
CN-1033858-C Preparation method of dicyclohexyl-3, 4, 3 ', 4' -tetracarboxylic dianhydride HITACHI CHEMICAL CO LTD (JP) 1997-01-22 CN disclosed
WO-1997001331-A2 METHOD OF PRODUCING SUSTAINED-RELEASE PREPARATION TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-01-16 WO disclosed
CN-1139124-A Dicyclohexyl-3,4,3',4'-tetracarboxylic acid or dianhydride thereof and polyamide-acid and polyimide obtained therefrom HITACHI CHEMICAL CO LTD (JP) 1997-01-01 CN disclosed
US-5536614-A FLUOROPOLYMER NEC CORPORATION (JP) 1996-07-16 US disclosed
US-5534269-A Method of producing sustained-release preparation TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-07-09 US disclosed
WO-1996007399-A1 SUSTAINED RELEASE PREPARATION CONTAINING METAL SALT OF A PEPTIDE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-03-14 WO disclosed
US-5489683-A HEAT RESISTANCE, OXIDATION RESISTANCE CIBA-GEIGY CORPORATION (US) 1996-02-06 US disclosed
WO-1996002276-A2 NOVEL POLYMER GEL NETWORKS AND METHODS OF USE GEL SCIENCES, INC. (US) 1996-02-01 WO disclosed
US-5482808-A SMALL PARTICLES COATED WITH FLUOROPOLYMER NEC CORPORATION (JP) 1996-01-09 US disclosed
EP-0548015-B1 Tetramethylpiperidine compounds for use as stabilisers for organic materials CIBA GEIGY AG (CH) 1996-01-03 EP disclosed
US-5463058-A Light, heat and oxidation stabilizers for synthetic polymers CIBA-GEIGY CORPORATION (US) 1995-10-31 US disclosed
US-5460913-A Homogeneous dispersion of pigment in polymerizable monomer HODOGAYA CHEMICAL CO., LTD. (JP) 1995-10-24 US disclosed
US-5457143-A Light, heat and oxydiation resistance CIBA-GEIGY CORPORATION (US) 1995-10-10 US disclosed
US-5455308-A Endless objects from epoxy resin or unsaturated polyester and thermoplastic polymer DSM N.V. (NL) 1995-10-03 US disclosed
US-5424165-A Printing durability, storage stability FUJI PHOTO FILM CO., LTD. (JP) 1995-06-13 US disclosed
US-5416216-A Tetramethylpiperidine compounds for use as stabilizers for organic materials CIBA-GEIGY CORPORATION (US) 1995-05-16 US disclosed
EP-0633020-A1 Method of producing sustained-release preparation TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-01-11 EP disclosed
EP-0518197-B1 Piperidine derivatives MITSUBISHI PETROCHEMICAL CO (JP) 1994-12-21 EP disclosed
EP-0617336-A2 Electrostatic image developer NEC CORPORATION (JP) 1994-09-28 EP disclosed
US-5332816-A Photostabilizers and oxidation resistance CIBA-GEIGY CORPORATION (US) 1994-07-26 US disclosed
CN-1024543-C Preparation method of dicyclohexyl-3, 4, 3 ', 4' -tetracarboxylic acid HITACHI CHEMICAL CO LTD (JP) 1994-05-18 CN disclosed
US-5310767-A FOR POLYMERS CIBA-GEIGY CORPORATION (US) 1994-05-10 US disclosed
CN-1085890-A Dicyclohexyl-3, 4, 3 ', 4' -tetracarboxylic acid or dianhydride thereof and polyamide-acid and polyimide obtained therefrom HITACHI CHEMICAL CO LTD (JP) 1994-04-27 CN disclosed
US-5306495-A Light, heat and oxidation resistance CIBA-GEIGY CORPORATION (US) 1994-04-26 US disclosed
EP-0304122-B1 Thermosetting composition DSM NV (NL) 1993-11-18 EP disclosed
US-5260443-A For polyolefin films MITSUBISHI PETROCHEMICAL COMPANY LIMITED (JP) 1993-11-09 US disclosed
US-5240629-A REFRIGERANT COMPOSITIONS ETHYL CORPORATION (US) 1993-08-31 US disclosed
EP-0547578-A1 Light-sensitive composition FUJI PHOTO FILM CO., LTD. (JP) 1993-06-23 EP disclosed
EP-0548015-A1 Tetramethylpiperidine compounds for use as stabilisers for organic materials CIBA-GEIGY AG (CH) 1993-06-23 EP disclosed
US-5217642-A Water soluble; detergent additives BASF AKTIENGESELLSCHAFT (DE) 1993-06-08 US disclosed
US-5210118-A Phenyl-3-Pyrazolidinones CIBA-GEIGY CORPORATION (US) 1993-05-11 US disclosed
US-5196457-A DUAL CURE EPOXY PREPREG CONTAINING UNSATURATED POLYESTER DSM N.V. (NL) 1993-03-23 US disclosed
EP-0528470-A2 Endless objects DSM N.V. (NL) 1993-02-24 EP disclosed
US-5189172-A Useful as photostabilizer or as intermediates for pharmaceuticals and agricultural chemicals MITSUBISHI PETROCHEMICAL COMPANY LIMITED (JP) 1993-02-23 US disclosed
EP-0523007-A1 Novel tetramethylpiperidine compounds for use as stabilisers for organic materials CIBA-GEIGY AG (CH) 1993-01-13 EP disclosed
EP-0518197-A1 Piperidine derivatives Mitsubishi Chemical Corporation (JP) 1992-12-16 EP disclosed
EP-0517658-A1 Stabilisation of polymeric organic materials by using synergistic mixtures comprising sterically hindered cyclic amines and derivatives of 3-pyrazolidinone or 1,2,4-triazolidine-3,5-dione CIBA-GEIGY AG (CH) 1992-12-09 EP disclosed
EP-0232224-B1 PIPERIDINE COMPOUNDS CIBA-GEIGY AG (CH) 1992-11-25 EP disclosed
EP-0242891-B1 SHEET MOULDING COMPOUND AND AN UPPER LAYER FOR IT DSM RESINS B.V. (NL) 1992-11-11 EP disclosed
EP-0483606-A2 Use of polyesters comprising condensed tartaric acid as detergent additive, process for production of the polyesters, and polyesters based upon tartaric acid and tetracarboxylic acids BASF Aktiengesellschaft (DE) 1992-05-06 EP disclosed
EP-0462068-A2 A method for stabilizing synthetic thermoplastic materials against thermal degradation CIBA-GEIGY AG (CH) 1991-12-18 EP disclosed
US-5030729-A Stabilizing Polyolefins Against Oxidative, Thermal And-Or Light Induced Degradation CIBA-GEIGY CORPORATION (US) 1991-07-09 US disclosed
US-5026770-A Resin composition and process for preparing this resin composition STAMICARBON B.V. (NL) 1991-06-25 US disclosed
EP-0274156-B1 TRANSPARENT PLATE FOR OPTICALLY READABLE INFORMATION CARRIER DSM N.V. (NL) 1991-03-13 EP disclosed
EP-0412588-A2 Epoxy prepreg Ligustica S.A. (CH) 1991-02-13 EP disclosed
EP-0410934-A2 Piperazine-piperidine compounds for use as stabilizers for organic materials CIBA-GEIGY AG (CH) 1991-01-30 EP disclosed
CN-1010292-B Sheet molding compound (SMC) and surface layer thereof DSM RESINS BV (NL) 1990-11-07 CN disclosed
US-4948821-A Shrinkage resistance, gloss, colorability, strenth and weather resistance STAMICARBON B.V. (NL) 1990-08-14 US disclosed
EP-0377258-A1 Resin composition and process for preparing this resin composition STAMICARBON B.V. (NL) 1990-07-11 EP disclosed
US-4927925-A Piperidine compounds and their use as thermal stabilizers CIBA-GEIGY CORPORATION (US) 1990-05-22 US disclosed
US-4927701-A Sheet moulding compound and a top for it DSM RESINS B.V. (NL) 1990-05-22 US disclosed
EP-0354184-A2 Compounds containing substituted piperidine groups for use as stabilizers for organic materials CIBA-GEIGY AG (CH) 1990-02-07 EP disclosed
EP-0107805-B1 MIXED 2,2,6,6-TETRAMETHYL PIPERIDINYL CARBOXYLIC ACID ESTER AND AMIDE LIGHT STABILIZERS AND STABILIZED SYNTHETIC POLYMERS ADEKA ARGUS CHEMICAL CO., Ltd. (JP) 1989-12-13 EP disclosed
EP-0339171-A1 Styrene emission inhibited unsatured polyester resin composition STAMICARBON B.V. (NL) 1989-11-02 EP disclosed
CN-1034707-A Dicyclohexyl-3, 4, 3 ', 4' -tetracarboxylic acid or dianhydride thereof and polyamide-acid and polyimide obtained therefrom HITACHI CHEMICAL CO LTD (JP) 1989-08-16 CN disclosed
EP-0312167-A2 Laminate structure DSM N.V. (NL) 1989-04-19 EP disclosed
EP-0304122-A1 Thermosetting composition DSM N.V. (NL) 1989-02-22 EP disclosed
US-4803234-A Piperidine compounds and their use as anti-oxidative, light or thermal induced degradation agents CIBA-GEIGY CORPORATION (US) 1989-02-07 US disclosed
EP-0274156-A2 Transparent plate for optically readable information carrier DSM N.V. (NL) 1988-07-13 EP disclosed
EP-0242891-A2 Sheet moulding compound and an upper layer for it DSM RESINS B.V. (NL) 1987-10-28 EP disclosed
CN-87102000-A Mold pressing composite board and surface lining thereof 1987-09-09 CN disclosed
US-4681686-A FROM (ALK)ACRYLIC ACID, HYPOPHOSPHOROUS ACID(SALT), ANTISCALING, CORROSION RESISTANCE, DISPERSANTS, PROTECTIVE COATINGS FMC CORPORATION, A CORP. OF DE 1987-07-21 US disclosed
EP-0108993-B1 OLIGOMERS OF 2,2,6,6-TETRAMETHYLPIPERIDINOL, POLYCARBOXYLIC ACID ESTERS AND SYNTHETIC POLYMER COMPOSITIONS ADEKA ARGUS CHEMICAL CO., Ltd. (JP) 1986-12-17 EP disclosed
US-4619958-A Mixed 2,2,6,6-tetramethyl piperidinyl carboxylic acid ester and amide light stabilizers and stabilized synthetic polymers ADEKA ARGUS CHEMICAL CO., LTD. (JP) 1986-10-28 US disclosed
US-4529760-A Oligomers of 2,2,6,6-tetramethylpiperidinol polycarboxylic acid esters and synthetic polymer compositions ADEKA ARGUS CHEMICAL CO., LTD. (JP) 1985-07-16 US disclosed
EP-0118658-A1 Process for the production of a pasty detergent Henkel Kommanditgesellschaft auf Aktien (DE) 1984-09-19 EP disclosed
EP-0108993-A1 Oligomers of 2,2,6,6-tetramethylpiperidinol, polycarboxylic acid esters and synthetic polymer compositions ADEKA ARGUS CHEMICAL CO., Ltd. (JP) 1984-05-23 EP disclosed
EP-0107805-A2 Mixed 2,2,6,6-tetramethyl piperidinyl carboxylic acid ester and amide light stabilizers and stabilized synthetic polymers ADEKA ARGUS CHEMICAL CO., Ltd. (JP) 1984-05-09 EP disclosed
US-4257958-A INORGANIC BORON-OXYGEN COMPOUND ADDITIVES TEXACO INC. (US) 1981-03-24 US disclosed
US-4215000-A CROWN ETHER COMPLEXES; RAPID REACTION SHELL DEVELOPMENT COMPANY (US) 1980-07-29 US disclosed
US-4196271-A 2-CYANOACRYLATE, POLYCARBOXYLIC ACID IMPACT STRENGTH IMPROVER TOAGOSEI CHEMICAL INDUSTRY CO., LTD. (JP) 1980-04-01 US disclosed
US-4086334-A A CALCITONIN AND AN ADJUVANT CONTAINING CARBOXY AND/OR PHOSPHONO GROUPS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DT) 1978-04-25 US disclosed
US-4086334-A A CALCITONIN AND AN ADJUVANT CONTAINING CARBOXY AND/OR PHOSPHONO GROUPS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DT) 1978-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (33 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267857-A1 SALT COMPOUND, CATIONIC POLYMERIZATION INITIATOR AND CATIONICALLY POLYMERIZABLE COMPOSITION RFC5, RER1, ARF5 TDP1 3143/4885SMN1; SMN2 3384/4885SLC22A6 2865/4885
US-20260055178-A1 ANTIBODY FORMULATIONS IL15, IL23R, HM13 TDP1 3426/4885SMN1; SMN2 2064/4885SLC22A6 721/4885
US-20260049132-A1 ANTI-CONNEXIN ANTIBODY FORMULATIONS SOST, GJA1, CD44 TDP1 3378/4885SMN1; SMN2 1879/4885SLC22A6 239/4885
US-20090069599-A1 PROCESS FOR PRODUCING TRICARBOXYLIC ACID TRIS (ALKYL-SUBSTITUTED CYCLOHEXYLAMIDE) ACMSD, CPS1, COASY TDP1 2666/4885SMN1; SMN2 4288/4885SLC22A6 850/4885
US-20200270236-A1 EPOXY-OXETANE COMPOUND, METHOD FOR SYNTHESIZING SAME, AND USE OF SAID COMPOUND OXER1, DHPS, OXGR1 TDP1 3832/4885SMN1; SMN2 3331/4885SLC22A6 4651/4885
US-20120289697-A1 NOVEL SULFONIC ACID DERIVATIVE COMPOUND AND NOVEL NAPHTHALIC ACID DERIVATIVE COMPOUND TPD52L2, TST, SULT1A1 TDP1 4721/4885SMN1; SMN2 3829/4885SLC22A6 498/4885
US-20100201019-A1 Method and composition for reducing waste in photo-imaging applications PARG, PHOSPHO1, FLNA TDP1 653/4885SMN1; SMN2 1997/4885SLC22A6 2787/4885
US-20030068374-A1 Sustained release preparations of physiologically active compound hardly soluble in water and production process and use of the same CHERP, VMA21, ATP2A1 TDP1 3477/4885SMN1; SMN2 584/4885SLC22A6 436/4885
US-20090117033-A1 INJECTABLE BIODEGRADABLE PARTICLES HACD3, HACD2, CD44 TDP1 2494/4885SMN1; SMN2 2125/4885SLC22A6 1176/4885
US-20030198676-A1 Sustained-release preparation for AII antagonist, production and use thereof AGTR2, AGTR1, PER2 TDP1 4719/4885SMN1; SMN2 3551/4885SLC22A6 1180/4885
US-20110152540-A1 AROMATIC SULFONIUM SALT COMPOUND SLC43A1, SLC7A5, SPIN2B TDP1 3591/4885SMN1; SMN2 740/4885SLC22A6 784/4885
US-20090093506-A1 Copper antagonist compositions HMGCR, SLC10A1, PCSK9 TDP1 3983/4885SMN1; SMN2 1356/4885SLC22A6 92/4885
US-20130078232-A1 COMPOSITIONS AND METHODS USEFUL FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS SMURF1, TTR, ALB TDP1 3890/4885SMN1; SMN2 1166/4885SLC22A6 2173/4885
US-20080033072-A1 Ink composition and inkjet ink, and image-forming method and recorded material using the same, and oxetane compound OXER1, IPO11, NOXO1 TDP1 1707/4885SMN1; SMN2 4118/4885SLC22A6 3815/4885
US-20050038236-A1 Imidazolidinone derivatives C9, CBR1, GCN1 TDP1 3596/4885SMN1; SMN2 3564/4885SLC22A6 4508/4885
US-10913731-B2 Epoxy-oxetane compound, method for synthesizing same, and use of said compound OXER1, DHPS, OXGR1 TDP1 3832/4885SMN1; SMN2 3331/4885SLC22A6 4651/4885
US-20080241416-A1 POLYMERIZABLE COMPOUND, POLYMER, INK COMPOSITION, PRINTED ARTICLES AND INKJET RECORDING METHOD CNOT1, CCNT1, SCO2 TDP1 2711/4885SMN1; SMN2 1372/4885SLC22A6 3673/4885
US-20030064912-A1 Pharmaceutical compositions and methods of inhibiting angiogenesis using NAALADase inhibitors NAALAD2, DNPEP, DPP9 TDP1 1577/4885SMN1; SMN2 3612/4885SLC22A6 1713/4885
US-20020168337-A1 Sustained-release preparation EDNRA, EDNRB, ORAI1 TDP1 1826/4885SMN1; SMN2 260/4885SLC22A6 613/4885
US-20030073835-A1 Light, heat and oxidation resistance; stabilizers CBR1, CYC1, MT-CO1 TDP1 3297/4885SMN1; SMN2 2462/4885SLC22A6 3790/4885
US-20020058622-A1 Sustained-release preparation EDNRA, EDNRB, ORAI1 TDP1 1826/4885SMN1; SMN2 260/4885SLC22A6 613/4885
US-20040219208-A1 Sustained-release medicines ACE, AGTR2, AGT TDP1 3616/4885SMN1; SMN2 3303/4885SLC22A6 440/4885
US-20120288441-A1 INJECTABLE BIODEGRADABLE PARTICLES HACD3, HACD2, CD44 TDP1 2564/4885SMN1; SMN2 2073/4885SLC22A6 1193/4885
US-20010044459-A1 Hydroxamic acid derivatives NAALAD2, DNPEP, NAAA TDP1 1233/4885SMN1; SMN2 3640/4885SLC22A6 1058/4885
US-20120136155-A1 AROMATIC SULFONIUM SALT COMPOUND F12, ASIC1, SPIN1 TDP1 4266/4885SMN1; SMN2 2549/4885SLC22A6 1647/4885
US-20170224820-A1 COMPOSITIONS AND METHODS USEFUL FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS SMURF1, TTR, ALB TDP1 3890/4885SMN1; SMN2 1166/4885SLC22A6 2173/4885
US-20110039205-A1 SULFONIUM SALT, PHOTOACID GENERATOR, AND PHOTOCURABLE COMPOSITION AND CURED BODY THEREOF ARSA, ASIC1, TST TDP1 4498/4885SMN1; SMN2 1788/4885SLC22A6 2119/4885
US-20100291017-A1 Hair Treatment Compositions OAT, NACA, BCAT2 TDP1 2858/4885SMN1; SMN2 4435/4885SLC22A6 46/4885
US-20120130117-A1 AROMATIC SULFONIUM SALT COMPOUND SLC6A19, ARSA, PAH TDP1 4292/4885SMN1; SMN2 4241/4885SLC22A6 1402/4885
US-20040121008-A1 Process for producing sustained release preparation VMA21, PUF60, SAMM50 TDP1 3626/4885SMN1; SMN2 1054/4885SLC22A6 305/4885
US-20130058958-A1 COMPOSITIONS AND METHODS USEFUL FOR REDUCING THE VISCOSITY OF PROTEIN-CONTAINING FORMULATIONS QPCTL, PTMS, CRYAA TDP1 2451/4885SMN1; SMN2 1844/4885SLC22A6 1917/4885
US-20030109609-A1 Thioimidazolidine derivatives as light stabilizers for polymers CCT4, GCN1, CBR1 TDP1 1527/4885SMN1; SMN2 2267/4885SLC22A6 4417/4885
US-20090093542-A1 Copper antagonist compositions ACE, CTRB2, AGTR2 TDP1 3717/4885SMN1; SMN2 1000/4885SLC22A6 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.